april 26 - 28, 2006 · 2005-04-22 · about cvrf angioplasty summit 2005 - tct asia pacific lay-out...

www.summitMD.com

Venue_ The Convention Center of Sheraton Grande Walkerhill Seoul Hotel, Seoul, Korea

Course Directors_ Seung-Jung Park, MD / Gary S. Mintz, MD

Seoul, April 28 - 30, 2005

Secretariat Angioplasty Summit 2005-TCT Asia Pacific388-1 Poongnap-2dong, Songpa-gu, Seoul, 138-736, KoreaTel: 82-2-3010-4799/4689 Fax: 82-2-475-6898E-mail:[email protected]

[email protected]: www.summitMD.com, www.cvrf.org

050425

April 26 - 28, 2006Please mark the schedule on your calender.Looking forward to your presence.

Abo

ut C

VRF

Angioplasty Summit 2005 - TCT Asia Pacific

Invi

ted

Facu

lty

Mee

ting

at a

Gla

nce

Con

tent

sFo

cus

Pro

gram

Abs

trac

tLa

y-O

utO

ffic

ial A

bstr

act G

rade

rs

Starting with the new formatAngioplasty Summit – TCT Asia Pacific

Welcome!!The Angioplasty Summit-TCT Asia Pacific is pleased to welcome andinvite interventional cardiologists, radiologists, clinical cardiologists,basic scientists, vascular medicine specialists, surgeons, and otherhealth care professionals with a special interest in the field ofinterventional vascular therapy and medicine to Seoul during itsmost beautiful season.

For 2005, the Angioplasty Summit has been arranging manyattractive new trials to meet the attendees’ various educationalneeds. The meeting will feature an exclusive TCT session moderatedby Doctors Martin B. Leon, and Gregg W. Stone. There will also be aEuroPCR session to overview the EuroPCR 2004 with its keyfaculties. Satellite live case transmissions will be relayed from 7remote sites including Columbia University Medical Center, USA, andColumbus Hospital, Italy. Case review sessions will be directed byleading scholars with interesting and challenging cases throughoutthe world. There will also be a moderated abstract presentationsession and an Outstanding Research Award. And of special note, theabstracts are to be published in ‘The American Journal ofCardiology’ and will thereby upgrade the meeting’s educationalvalue.

With the undertaking of these collaborations, the AngioplastySummit intends to make itself a leading educational event in theAsian Pacific area and a platform for exchanging useful ideasbetween Western and Asian Pacific colleagues. By visiting andengaging in the Angioplasty Summit-TCT Asia Pacific, you can find acommunication gateway to the most recent trends and clinical trialupdates in this field.

Esteemed medical colleagues, we invite you to please participate inthe 10th Anniversary Angioplasty Summit-TCT Asia Pacific, torespectfully learn from the international experts and swim with thetide of the latest education in interventional cardiology.

Table of Contents

Course Directors

Starting with the new format

Angioplasty Summit - TCT Asia Pacific

Focus

Invited FacultyInternational Faculty

Korean Faculty

Meeting at a Glance

ProgramThursday _ April 28

Friday _ April 29

Saturday _ April 30

Official Abstract Graders

Oral Abstract Presentations

Poster Abstract Presentations

About CVRF

Contributor Acknowledgement

Exhibit Booth Lay-Out

Venue Lay-Out

02

03

04

06

08

09

10

12

17

21

22

23

39

40

41

42

Organizing CommitteeMyeong-Ki Hong, MD Yang Soo Jang, MD Myung-Ho Jeong, MD Hyo-Soo Kim, MDJae-Joong Kim, MD Jae-Ki Ko, MD Dong Joo Oh, MD Ki Bae Seung, MDSeung-Jea Tahk, MD Joo-Young Yang, MD

Scientific Committee

Angioplasty Summit 2005 Associations and AffiliationsCardioVascular Research Foundation Asia(CVRF) / Asan Medical Center, Seoul, Korea

Cardiovascular Research Foundation (CRF)/ Columbia University Medical Center, New York, USATranscatheter Cardiovascular Therapeutics (TCT)The Paris Course on Revascularization (EuroPCR)

Complex Catheter Therapeutics (CCT)Asian Pacific Society of Interventional Cardiology (APSIC)

The Korean Society of CirculationThe Korean Society of Interventional Cardiology

Course Directors Seung-Jung Park, MD

Gary S. Mintz, MD

Course Co- Directors Seong-Wook Park, MDJohn R. Laird, MD Hideo Tamai, MD Alan C. Yeung, MD

TCT Asia Pacific Co-Directors Martin B. Leon, MDGregg W. Stone, MD

Maurice Buchbinder, MD Charles Chan, MDAntonio Colombo, MD Runlin Gao, MD Junbo Ge, MD Eberhard Grube, MDYaling Han, MD Mun Kyung Hong, MDYong Huo, MD Ik-Kyung Jang, MDOsamu Katoh, MD Yean-Leng Lim, MDJean Marco, MD Jeffrey W. Moses, MDShigeru Saito, MD Teguh Santoso, MDPatrick W. Serruys, MD Takahiko Suzuki, MDTetsu Yamaguchi, MD

Seung-Yun Cho, MD Gyu-Bo Choi, MD Hyeon-Cheol Gwon, MD Jung Chaee Kang, MDKwon-Bae Kim, MD Young-Jo Kim, MDSang Hoon Lee, MD Byung-Hee Oh, MDJeong Euy Park, MD Young-Bae Park, MD Won-Heum Shim, MD Eak-Kyun Shin, MD Junghan Yoon, MD

Sponsored by

Abo

ut C

VRF


Invi

ted

Facu

lty

Mee

ting

at a

Gla

nce

Con

tent

sFo

cus

Pro

gram

Abs

trac

tLa

y-O

utO

ffic

ial A

bstr

act G

rade

rs

Focus

THE MAIN ARENAThursday_1:00 pm~6:30 pm

Friday_8:30 am~6:00 pm

Saturday_8:30 am~4:00 pm

Live Case Demonstrations

State-of-the-art Lectures

TCTAP session

EuroPCR at Angioplasty Summit

TopicsClinical trial updates 2005

Drug-eluting stents

Novel strategies for high riskpatients and complex lesions

Acute coronary syndrome

Interventional pharmacology

Diagnosis and treatment ofvulnerable plaque

Brachytherapy

Angiomyogenesis

Alcohol septal ablation

PMV (percutaneous mitral balloonvalvuloplasty)

Peripheral Intervention

Nonionizing energy therapies forthe prevention and treatment ofrestenosis and the at-risk lesion

Nonsurgical approaches tostructural heart disease

Left ventricular dysfunction andhemodynamic support

Saphenous vein grafts andthrombotic lesions

LIVE CASETRANSMISSIONSITESINTERNATIONAL:

Columbia University Medical Center,New York, USA

San Raffaele Hospital, Milano, Italy

Toyohashi Heart Center, Aichi, Japan

Cardiovascular Institute & Fu WaiHospital, Beijing, China

KOREA:Asan Medical Center, Seoul

The Catholic University of Korea,Kangnam St. Mary's Hospital, Seoul

Pusan National University Hospital,Pusan

THE BESTABSTRACTPRESENTATIONSESSIONS

Oral Abstract SessionSaturday, April 30_12:30 pm~2:00 pm

The best abstracts for the AngioplastySummit 2005-TCT Asia Pacific will bepresented during lunchtime activities

Poster Abstract SessionFriday, April 29_9:00 am~11:00 am

2:00 pm~4:00 pm

Saturday, April 30_9:00 am~11:00 am

Moderated Poster AbstractPresentations

Moderated by world-celebrated experts,these presentations will honor the bestabstracts of the Angioplasty Summit2005-TCT Asia Pacific at the exhibit hall.

04/05 _ Focus

SYMPOSIAThese sessions sponsored by theorganizing committee and industrieswill complement the didactic materialfrom the main scientific sessions.

TUTORIALAUDITORIUM:How to – What toFriday, April 29_11:00 am~6:30 pm

Saturday, April 30_8:30 am~12:30 pm

“More Practical”“More Technical”

- Live Case Demonstrations

- State-of-the-art Lectures

TopicsTransradial intervention (TRI)

CTO intervention: new advancedtechnique

Peripheral intervention: carotidstenting, renal, and AAA

Platelet inhibition: new insightsinto aspirin and thienopyridineapplications, currentunderstanding and evolving rolesfor glycoprotein IIb/IIIa antagonists

Distal protection andthrombectomy devices in nativecoronary arteries and saphenousvein grafts

Diabetes and cardiovasculardisease: attacking the epidemic

Plaque modification anddebulking: atherotomy,atherectomy and laser

Angiomyogenesis

Top interventional cardiology trialsof the last year

Coronary stent design and newclinical trial insights

Heparin attack:low-molecular weight heparins,direct antithrombins

8th Annual Conference forCardiovascular Nurse &Technologist - organized by Cardiovascular

Technology Association (CTA)

Saturday, April 30_4:00 pm~5:30pm

Exhibit ActivitiesExhibit location

-Exhibit Hall, Level B1, Sheraton GrandeWalkerhill Seoul Hotel

Exhibit Hours

Thursday, April 28, 2005,

1:00 PM - 6:00 PM

Friday, April 29, 2005,

9:00 AM - 6:00 PM

Saturday, April 30, 2005,

9:00 AM - 4:00 PM

Official Language- English

SimultaneousTranslation ServicesEnglish into - Chinese

- Japanese- Korean

Satellite Evening SymposiaThursday, April 28_6:30 pm~8:30 pm

1_ The Future of DES and Complex PCI

2_ Virtual Histology; Beyond IVUS

3_ "ENDEAVOR"- What's New? What'sDifferent?

4_ Is Cypher the Best Choice?; ClinicalPerspectives of Cypher

Lunchtime ActivitiesFriday, April 29_12:30 pm~2:00 pm

1_ Angiomyogenesis

2_ Current Standards and ProposedDirections in PharmacologicApproaches for PCI

3_ Lipid Management : A New Era inThe Treatment of Coronary ArteryDisease

4_ Drug Eluting Stent Summit – III

5_ ”Reducing Cardiovascular Risk”– Keyword in ManagingHypertension and Lipid

Saturday, April 30, 12:30 pm~2:00 pm

6_ Why not TRI?

7_ Promise of Glitazone

8_ Advanced Endovascular Therapy:Cordis Clinical Results on Renal andSFA Stenting

9_ Oral Abstract Session"The Best Abstract Presentations"

Breakfast Meetings

CASE REVIEWS:MEET THE EXPERTS“Mini Lectures and CaseDiscussions”

Friday, April 29 and Saturday, April 30

_7:00 AM ~ 8:30 AM

These sessions may possibly be themost exciting part of this medicalconvention. They provide a small groupenvironment for mini lectures by worldrenowned experts and angiographiccase reviews regarding specific andclinical topics Five separate rooms perday will be offered during breakfasttime.

TopicsBifurcation Lesions

Drug Eluting Stent Summit II, IV

Acute Myocardial Infarction

Chronic Total Occlusions

Complex PCI

Left Main Lesions

Management of Complications

IVUS, OCT, Thrombectomy,Atherectomy, and Cutting

Peripheral Lesions

Abo

ut C

VRF


Invi

ted

Facu

lty

Mee

ting

at a

Gla

nce

Con

tent

sFo

cus

Pro

gram

Abs

trac

tLa

y-O

utO

ffic

ial A

bstr

act G

rade

rs

06/07 _ Invited Faculty

INTERNATIONALFACULTY

Alexandre Abizaid, MD Instituto Dante Pazzanese de Cardiologia, Brazil

Takashi Akasaka, MD Kawasaki Medical School, Japan

Yaron Almagor, MD Shaare Zedek Medical Center, Israel

Takayuki Asahara, MD Tokai University School of Medicine, Japan

Yasushi Asakura, MD Keio University School of Medicine, Japan

Narender O. Bansal, MD Grant Medical College and Sir J.J Group ofHospital, India

Suman Bhandari, MD Escorts Heart Institute, India

Giancarlo Biamino, MD Heart Center Leipzig, Germany

Maurice Buchbinder, MD Foundation for Cardiovascular Medicine, USA

Wacin Buddhari, MD King Chulalongkorn Memorial Hospital,Thailand

Charles Chan, MD Charles Chan heart Clinic, Singapore

Chi Kin Chan, MD Pamela Youde Nethersole Eastern Hospital,Hong Kong, China

Kam Tim Chan, MD Queen Elizabeth Hospital, Hong Kong, China

Wai Kwong Chan, MD United Christian Hospital, Hong Kong, China

Jilin Chen, MD Fuwai Hospital, China

Paul Chen, MD Taipei Medical University-Wan Fang Hospital,Taiwan

Yun-dai Chen, MD Beijing Anzhen Hopital, China

Kenneth Chin, MD Pantai Medical Centre, Malaysia

Chiayu Chou, MD Veterans General Hospital, Taiwan

Simon Liang Chow, MD Tuen Mun Hospital, Hong Kong, China

Antonio Colombo, MD Columbus Hospital, Italy

David Martin Colquhoun, MD The University of Queensland, Australia

Patrick Joseph Commerford, MD University of Cape Town and Head, South Africa

Sameer Indravadan Dani, MD Civil Hospital, Ahmedabad, Gujarat, India

Gian Battista Danzi, MD Ospedale Maggiore Policlinico, Italy

Anil Dhall, MD Army Hospital, India

Latchumana Dhas, MD Senior Consultant Institute of CardiovascularCardiologist Disease, India

Gerald Dorros, MD Dorros-Feuer Interventional CardiovascularDisease Foundation, USA

Shuvo Dutta, MD B. M. Birla Heart Research Centre, India

Eric Eeckhout, MD Cardiology University Hospital CHUV,Switzerland

Jean Fajadet, MDCardiologie interventionelle Clinique Pasteur,France

Robert Falotico, MD Cordis Corporation, USA

Ted Feldman, MD Evanston Hospital, USA

Carlos M. Ferrario, MD Wake Forest University School of Medicine, USA

Tohru Funahashi, MD Osaka University, Graduate School of Medicine,Japan

Anthony Fung, MD Vancouver General Hospital, Canada

Luyue Gai, MD PLA General Hospital, China

Runlin Gao, MD Fu Wai Hospital, China

Junbo Ge, MD Zhongshan Hospital, China

Eberhard Grube, MD Heart Center Siegburg, Germany

Mujeeb-Ul Haq, MD Consultant Cardiologist Hearts InternationalHospital Rawalpindi, Pakistan

David Sai-Wah Ho, MD St. Paul’s Hospital, Hong Kong, China

Duncan Hung Kwong Ho, MD Queen Elizabeth Hospital, Hong Kong, China

David R. Holmes, Jr, MD Mayo Clinic, USA

Hidehiko Honda,MD Sendai Kosei Hospital, Japan

Mun Kyung Hong, MD New York Presbyterian Hospital, USA

I Chang Hsieh, MD Chang Gung Memorial Hospital, Taiwan

Chien-Ming Huang, MD Cheng-Hsin Heart Center, Taiwan

Yong Huo, MD First Hospital Peking University, China

Juey-Jen Jim Hwang, MD National Taiwan University Hospital, Taiwan

Keiichi Igarashi, MD Hokkaido Social Insurance Hospital, Japan

Naoto Inoue, MD Kyoto 2nd Red Cross Hospital, Japan

Farouc A Jaffer, MD Massachusetts General Hospital, USA

Pramod Jaiswal, MD International Centre for Cardiothoracic andVascular Diseases, India

Ik-Kyung Jang, MD Massachusetts General Hospital, USA

Man-Hong Jim, MD Grantham Hospital, Hong Kong, China

Yoshifumi Kan, MD Shin-Yukuhashi Hospital, Japan

Honin Kanaya, MD Ishikawa Prefectural Central Hospital, Japan

Paul Hsien-Li Kao, MD National Taiwan University Hospital, Taiwan

Osamu Katoh, MD Toyohashi Heart Center, Japan

Upendra Kaul, MD Batra Hospital & Medical Research Centre, India

Takeshi Kimura, MD Kyoto University Hospital, Japan

Tien-Hai Koh, MD National Heart Centre, Singapore

Richard E. Kuntz, MD Brigham and Women's Hospital, USA

Vincent On-Hing Kwok, MD Hong Kong Sanatorium & Hospital, Hong Kong,China

Kenneth K.H. Lam, MD Baptist Hospital, Hong Kong, China

Kean-Wah Lau, MD National Heart Centre of Singapore, Singapore

Michael Kang-Yin Lee, MD Queen Elizabeth Hospital, Hong Kong, China

Pui-Yin Lee, MD Queen Mary Hospital, Hong Kong, China

Martin B. Leon, MD NewYork-Presbyterian Hospital / ColumbiaUniversity Medical Center, USA

Sum-Kin Leung, MD Kwong Wah Hospital, Hong Kong, China

Invited Faculty_Shu Kin Li, MD Pamela Yunde Nethersole Eastern Hospital,Hong Kong, China

Yi-Heng Li, MD National Cheng Kung University Hospital,Taiwan

Yean-Leng Lim, MD The University of Melbourne, Australia

Yean-Teng Lim, MD National University Hospital, Singapore

Meilin Liu, MD First Hospital, Beijing University, China

Shuzheng Lu, MD Beijing Anzhen Hospital Capital University ofMedicine, China

Raj R. Makkar, MD Cedars-Sinai Medical Center, USA

Keith L. March, MD Indiana Center for Vascular Biology andMedicine, USA

James R. Margolis, MD Miami Heart Institute, USA

Motomaru Masutani, MD Hyogo College of Medicine, Japan

Ian T. Meredith, MD Monash Medical Centre, Australia

Gary S. Mintz, MD Cardiovascular Research Foundation, USA

Kazuaki Mitsudo, MD Kurashiki Central Hospital, Japan

Kyoichi Mizuno, MD Chiba-Hokusoh Hospital, Japan

Jeffrey W. Moses, MDNewYork-Presbyterian Hospital / ColumbiaUniversity Medical Center, USA

Ajit Sankardas Mullasari, MD Madras Medical Mission Hospital, India

Toshiya Muramatsu, MD Kawasaki Social Insurance Hospital, Japan

Masato Nakamura, MDToho University School of Medicine OhashiHospital, Japan

Sunao Nakamura, MD New Tokyo Hospital, Japan

Richard Ng, MD Elizabeth Medical Center, Singapore

Swee Choon Ng, MD Interventional Cardiovascular Society ofMalaysia, Malaysia

Koen Nieman, MD Massachusetts General Hospital, USA

Masahiko Ochiai, MD Showa University Hokubu Hospital, Japan

Takashi Okada, MD Nantan General Hospital, Japan

John Ormiston, MD Green Lane and Mercy Hospital, New Zealand

Ma Ostovan, MD Shiraz Medical School, Iran

Ian M. Penn, MD Vancouver General Hospital, Canada

Jayesh S. Prajapati, MD U. N. Mehta Cardiology Institute and ResearchCentre Civil Hospital Campus, India

S.S. Ramesh, MD Ramesh Cardiology Associates, India

William C. Roberts, MD Baylor Heart & Vascular Hospital, USA

Krishna Rocha-Singh, MD Southern Illinois University School of Medicine,USA

Mohd Ali Rosli, MD Consultant Cardiologist National Heart Institute,Malaysia

Shigeru Saito, MD Shonan Kamakura General Hospital, Japan

Hideaki Sakai, MD Nagasaki Zeshinkai Hospital, Japan

Mathew Samuel Kalarickal, MD Apollo Hospital, India

Teguh Santoso, MD University of Indonesia Medical School,Indonesia

Ashok Seth, MD Max Devki Devi Heart & Vascular Institute, India

Takaaki Shiono, MD Shonan Kamakura General Hospital, Japan

Marc Silvestri, MD Private Hospital Parc Rambot-Aix en Provence,France

Mark Simmonds, MD Wellington Hospital, New Zealand

Balbir Singh, MD Escorts Heart Institute and Research Center,India

Nakul Sinha, MD Sanjay Gandhi Post Graduate Institute ofMedical Sciences, India

Stephen Alistair Smith, MD GlaxoSmithKline, United Kingdom

Christodoulos Stefanadis, MD Medical School of Athens University, Greece

Gregg W. Stone, MD NewYork-Presbyterian Hospital/ColumbiaUniversity Medical Center, USA

Satoru Sumitsuji, MD Rinku General Medical Center, Japan

Takahiko Suzuki, MD Toyohashi Heart Center, Japan

Saeko Takahashi, MD ShonanKamakura General Hospital, Japan

Hideo Tamai, MD Shiga Medical Center for Adults, Japan

Ahmed Tawakol, MD Massachusetts General Hospital, USA

Mitsuyasu Terashima, MD Toyohashi Heart Center, Japan

Joy M Thomas, MD International Centre for Cardiothoracic andVascular Diseases, India

Tak-Fu Tse, MD 813 Medical Center, Hong Kong, China

Etsuo Tsuchikane, MD Toyohashi Heart Center, Japan

Nguyen Quang Tuan, MD Vietnam Heart Institute Bach Mai Hospital,Vietnam

D.Geoffrey Vince, PhD The Cleveland Clinic Foundation, USA

Renu Virmani, MD Armed Forces Institute of Pathology, USA

Masamichi Wada, MD Toho University Ohashi Hospital, Japan

Kenneth Walsh, PhD Whitaker Cardiovascular Institute, USA

Shih-Pu Wang, MD Cardiovascular Center, Tainan MunicipalHospital, Taiwan

Udayachalerm Wasan, MD King Chulalongkorn Memorial Hospital,Thailand

Charles Inman Wilmer, MD Cardiac Disease Specialists, P.C, USA

Chiung-Jen Wu, MD Chang-Gung Memorial Hospital, Taiwan

Tetsu Yamaguchi, MD Toranomon Hospital, Japan

Takehiro Yamashita, MD Hokkaido Ohno Hospital, Japan

Alan C. Yeung, MD Stanford University Medical Center, USA

Andrew Zalewski, MD GlaxoSmithKline, USA

Robaayah Zambahari, MD National Heart Institute, Malaysia

Shu Yang Zhang, MD Peking Union Medical College Hospital, China

Abo

ut C

VRF


Invi

ted

Facu

lty

Mee

ting

at a

Gla

nce

Con

tent

sFo

cus

Pro

gram

Abs

trac

tLa

y-O

utO

ffic

ial A

bstr

act G

rade

rs

08/09 _ Invited Faculty/Meeting at a Glance

Invited Faculty_

KOREANFACULTY

Taehoon Ahn, MD Gil Medical Center

Young-Keun Ahn, MD Chonnam National University Hospital

In-Ho Chae, MD Seoul National University Hospital

Jei Kun Chai, MD Chonbuk National University Hospital

Sang-Sig Cheong, MD Gangneung Asan Hospital

Seung-Yun Cho, MD Yonsei University Severance Hospital

Yoon Haeng Cho, MD Soonchunhyang University Hospital

Dong Hoon Choi, MD Yonsei University Severance Hospital

Dong Ju Choi, MD Seoul National University Hospital

Gyu-Bo Choi, MD The Catholic University of Korea, St. Mary'sHospital

Kook-Jin Chun, MD Pusan National University Hospital

Wook-Sung Chung, MD The Catholic University of Korea, St. Mary'sHospital

Hyeon-Cheol Gwon, MD Samsung Medical Center

Ki Hoon Han, MD Asan Medical Center

Kyoo-Rok Han, MD Hallym Kangdong Sacred Heart Hospital

Jung-Ho Heo, MD Kosin University Gospel Hospital

Myeong-Ki Hong, MD Asan Medical Center

Taeg Jong Hong, MD Pusan National University Hospital

Young Joon Hong, MD Chonnam National University Hospital

Seung-Ho Hur, MD Keimyung University Dongsan Medical Center

Hweung Kon Hwang, MD Sejong Hospital

Yang-Soo Jang, MD Yonsei University Severance Hospital

Myung-Ho Jeong, MD Chonnam National University Hospital

Jung Chaee Kang, MD Chonnam National University Hospital

Chong-Jin Kim, MD The Catholic University of Korea, St. Paul'sHospital

Duk-Kyung Kim, MD Samsung Medical Center

Hyo-Soo Kim, MD Seoul National University Hospital

Hyun Sook Kim, MD Chonbuk National University Hospital

Jae-Joong Kim, MD Asan Medical Center

Jeong Hyun Kim, MD Hanyang University Medical Center

Jun Hong Kim, MD Pusan National University Hospital

Kee-Sik Kim, MD Keimyung University Dongsan Medical Center

Kwon-Bae Kim, MD Keimyung University Dongsan Medical Center

Moo Hyun Kim, MD Dong-A University Medical Center

Pum Joon Kim, MD The Catholic Universtiy of Korea, St. Mary'sHospital

Seong Man Kim, MD Inje University Pusan Baik Hospital

Young Dae Kim, MD Dong-A University Medical Center

Young Jo Kim, MD Yeungnam University Medical Center

Young-Hak Kim, MD Asan Medical Center

Jae-Ki Ko, MD Chonbuk National University Hospital

Bon-Kwon Koo, MD Seoul National University Hospital

Hyuckmoon Kwon, MD Yonsei University Severance Hospital

Cheol-Whan Lee, MD Asan Medical Center

Jae-Hwan Lee, MD Chungnam National University Hospital

Keun Lee, MD Seoul Veterans Hospital

Nae Hee Lee, MD Soonchunhyang University Hospital

Sang Gon Lee, MD Ulsan Asan Medical Center

Sang Hoon Lee, MD Samsung Medical Center

Seung-Hwan Lee, MD Yonsei University Wonju Christian Hospital

Seung-Whan Lee, MD Soon Chun Hyang University Bucheon Hospital

Sang Wook Lim, MD Bundang CHA Medical Center

Deuk Young Nah, MD Dongguk University Kyongju Hospital

Byung-Hee Oh, MD Seoul National University Hospital

Dong Joo Oh, MD Korea University Kuro Hospital

HoonKi Park, MD Seoul Veterans Hospital

Hun Sik Park, MD Kyung Pook National University Hospital

Jae Hyeong Park, MD Chonbuk National University Hospital

Jeong Bae Park, MD Samsung Cheil Hospital

Jeong Euy Park, MD Samsung Medical Center

Keum Soo Park, MD Inha University Hospital

Seong-Wook Park, MD Asan Medical Center

Seung-Jung Park, MD Asan Medical Center

Young-Bae Park, MD Seoul National University Hospital

In-Whan Seong, MD Chungnam National University Hospital

Ki Bae Seung, MD The Catholic University of Korea, St. Mary'sHospital

Won-Heum Shim, MD Yonsei University Severance Hospital

Eak-Kyun Shin, MD Gil Medical Center

Jae-Kwan Song, MD Asan Medical Center

Dae Chul Suh, MD Asan Medical Center

Kyu Bo Sung, MD Asan Medical Center

Seung-Jea Tahk, MD Ajou University Medical Center

Joo-Young Yang, MD NHIC Ilsan Hospital

Hyun Ki Yoon, MD Asan Medical Center

Junghan Yoon, MD Yonsei University Wonju Christian Hospital

Meeting at a Glance

AMC : ASAN MEDICAL CENTER, SEOUL

Abo

ut C

VRF


Invi

ted

Facu

lty

Mee

ting

at a

Gla

nce

Con

tent

sFo

cus

Pro

gram

Abs

trac

tLa

y-O

utO

ffic

ial A

bstr

act G

rade

rs

10/11 _ Program

4:45 PM The Endeavor DESProgram (Focus on Endeavor 2) Richard E. Kuntz

5:00 PM The Biolimus A9 DESProgram(Focus on Stealth 1)Eberhard Grube

5:15 PM Discussion

Live Case Session 1

5:30 PM Asan Medical Center,Seoul, Korea

Cases #1, #2

Moderators: Gregg W. StoneAlan C. Yeung

Discussants: Alexandre AbizaidMaurice BuchbinderCharles ChanEberhard GrubeDavid R. Holmes,Jr Yang-Soo JangTakeshi KimuraRichard E. KuntzKi Bae SeungSeung-Jea Tahk

Operators: Myeong-Ki HongMartin B. LeonSeong-Wook ParkSeung-Jung ParkRobaayah Zambahari

IVUS Interpretator: Gary S. Mintz

6:30 PM Adjourn

3_"ENDEAVOR"- What's New ? What's Different ? Cosmos Room, Level 3

Sponsored by Medtronic Korea co., Ltd

Moderators: Ian T. MeredithRichard E. Kuntz

6:30 PM Buffet Dinner

7:00 PM Opening Remarks, MKL Top Management Joon Hurh

7:05 PM Overview of Endeavor IIClinical ResultsIan T. Meredith

7:20 PM Safety and Endeavor IISubsetsRichard E. Kuntz

7:40 PM Endeavor II in PerspectiveMartin B. Leon

8:00 PM Endeavor Q & A

Panelists:In-Ho ChaeMyeong-Ki HongRichard E. KuntzIan T. MeredithKi Bae Seung

4_Is Cypher the Best Choice? - ClinicalPerspectives of CypherArt Room, Level 4

Sponsored by Johnson & Johnson MedicalKorea Ltd.

Moderators: Martin B. LeonSeung-Jung Park


7:00 PM Opening Remark

7:10 PM Body of Evidence -SIRTAX, ISAR-DIABETES,ISAR-DESIRE, ARTS IIMartin B. Leon

7:30 PM REALITY Head-To-HeadComparison Alexandre Abizaid

7:50 PM Safety and Efficacy ofCypher on ComplexLesionSeung-Jung Park

8:10 PM Is Sirolimus Different fromAnalogues? Robert Falotico

8:30 PM Discussion and Q&A

Evening SymposiaSheraton Grande Walkerhill Seoul Hotel6:30 PM-8:30 PM

1_The Future of DES and Complex PCIMugunghwa Room 1, Level 1

Sponsored by Boston Scientific Korea Co., Ltd

Moderators: Gregg W. StoneSeong-Wook Park



7:10 PM Taxus V Clinical UpdateGregg W. Stone

7:30 PM Diabetic Performance inTaxus Myung-Ho Jeong

7:50 PM IVUS in Complex PCIAlan C. Yeung

8:10 PM Pre & Post-DilatationStrategies for DES Ted Feldman

8:30 PM Panel Discussion

2_Virtual Histology; Beyond IVUSMugunghwa Room 2, Level 1

Sponsored by DAEIL CO., LTD

Moderators: Gary S. MintzJames R. Margolis



7:10 PM Virtual History:Concept and ValidationD. Geoffrey Vince

7:30 PM Virtual Histology- ATechnical & Clinical UpdateGary S. Mintz

7:50 PM Real World Paradigm forIdentifying VulnerablePlaques and VulnerablePatientsJames R. Margolis

8:10 PM Q & A

Program_Thursday, April 28

2:30 PM Late Loss Remains theBest Single Indicator ofDES Performance!Richard E. Kuntz

2:45 PM The "Appropriate" Use ofIVUS During DESProceduresGary S. Mintz

3:00 PM DES PathobiologyConsiderations:What We Know and WhatWe Don't Know Can HurtUs!Renu Virmani

The Great Debate :

3:15 PM Why TAXUS Is Better ?Gregg W. Stone

3:30 PM Why CYPHER Is Better ?Martin B. Leon

InquisitorDavid R. Holmes, Jr

3:45 PM Coffee Break

Wrapping Up New Clinical Trials Updates 2005- from TCT, AHA, ACC

Moderators: Gregg W. StoneGary S. Mintz

4:00 PM Recent Updates from theTaxus Trials(Taxus 2 and 4 Late FU,Taxus Meta-Analysis, andTaxus 5)Gregg W. Stone

4:15 PM Recent Updates from theCypher Trials(Cypher Meta-Analysis,Diabetes, Late FU fromFIM and SIRIUS, ARTS II)Alexandre Abizaid

4:30PM A Critical Appraisal of the"Head-to-Head" Cyphervs. Taxus TrialsMartin B. Leon

THURSDAY, APRIL 28MAIN ARENAVista Hall, W-Hotel,Level B2, 1:00 PM~6:30 PM

1:00 PM Welcome AddressSeung-Yun Cho Chairman,The Korean Society ofCirculation

Angioplasty Summit 2005-TCT Asia Pacific Introduction

1:10 PM Launching of The JointConference - AngioplastySummit and TCT:Significance and FuturePerspectivesSeung-Jung Park

1:20 PM TCT Asia Pacific:Where We Are Going...Martin B. Leon

TCT ASIA PACIFIC

Drug Eluting Stent Summit - I


1:30 PM Are All Sirolimus AnalogsAlike?Robert Falotico

1:45 PM New Drug Eluting Stents Alexandre Abizaid

2:00 PM Is the TAXUS Stent BenefitExtended to the MostComplicated Patients andLesions?Eberhard Grube

2:15 PM The Perspective of DrugEluting Stent in the FutureMartin B. Leon

Abo

ut C

VRF


Invi

ted

Facu

lty

Mee

ting

at a

Gla

nce

Con

tent

sFo

cus

Pro

gram

Abs

trac

tLa

y-O

utO

ffic

ial A

bstr

act G

rade

rs

12:15 PM Pathology of VulnerablePlaqueRenu Virmani

12:30 PM Lunchtime ActivitiesPlease refer to page 15 -16

Live Case Session 4

2:00 PM Cardiovascular Institute &Fu Wai Hospital, Beijing,China

2:30 PM Asan Medical Center,Seoul, Korea

Cases #6, #7, #8

Moderators: Seung-JungPark Junbo Ge

Discussants:Narender O. BansalChi Kin ChanYong HuoIk-Kyung JangMyung-Ho JeongKee-Sik KimTakeshi KimuraRaj R. MakkarIan T. MeredithShih-Pu Wang

Cardiovascular Institute &Fu Wai Hospital, Beijing,China

Operators: Runlin GaoHaibo LiuShubin QiaoXuewan QinYongjian WuYuejin Yang

Asan Medical Center,Seoul, Korea

Operators: Yang-Soo JangMartin B. LeonJames R. MargolisKazuaki MitsudoTeguh SantosoJunghan Yoon


FRIDAY, APRIL 29

7:00 AM Breakfast Meetings Please refer to page 14-15

MAIN ARENAVista Hall, W-Hotel,Level B2, 8:30 AM~6:00 PM

Live Case Session 2

8:30 AM Columbia UniversityMedical Center, New York,USA

Moderators: Martin B. LeonGregg W. Stone

Discussants: Alexandre AdizaidTed Feldman Kyoo-Rok Han Kwon-Bae KimMichael Kang-Yin Lee Yean-Leng Lim Gary S. MintzSeong-Wook Park Seung-Jung Park Hideo Tamai

Operators: Stephane CarlierMichael CollinsGeorge D. DangasRoxana MehranJeffrey W. MosesIssam MoussaGiora Weisz

State-of-the-Art Lectures 1

Moderator: Seung-Yun Cho

10:00 AM Percutaneous Heart ValveTherapyMartin B. Leon

10:15 AM Virtual Histology - ATechnical and ClinicalUpdateGary S. Mintz

Live Case Session 3

10:30 AM The Catholic University, St.Mary's Hospital, Seoul,Korea

11:00 AM Asan Medical Center,Seoul, Korea

Cases #3, #4, #5

Moderators: Alan C. YeungSeong-Wook Park

Discussants: Anthony FungMun Kyung Hong Man-Hong Jim Duk-Kyung KimJeong Hyun KimRichard E. KuntzRichard NgJohn OrmistonKeum Soo ParkShigeru Saito

The Catholic University, St.Mary's Hospital, Seoul,Korea

Operators: Eberhard Grube Ki Bae Seung


Operators: Maurice BuchbinderWook-Sung ChungHyeon-Cheol GwonMasahiko OchiaiSeung-Jung ParkGregg W. Stone



Moderator: Young-Bae Park

12:00 PM What Are the Clinical Gapsand UnansweredQuestions for DES in 2005 ?David R. Holmes, Jr

12/13 _ Program

Program_Friday, April 29

State of the Art Lectures 2

Moderator: Eak-Kyun Shin

2:00 PM SYMBIOT III: A ProspectiveRandomized Trial of aPTFE Self-expandingStent Graft During SVGIntervention-Late ResultsMaurice Buchbinder

2:15 PM SFA Interventions(Including New Technique,CTO)Krishna Rocha-Singh

2:30 PM The E-valve Edge-to-EdgeRepair for MitralRegurgitation:Design Concept andEVEREST UpdateTed Feldman

2:45 PM Carotid Stenting withProtection DevicesPaul Hsien-Li Kao

Live Case Session 2

3:00 PM Cardiovascular Institute &Fu Wai Hospital, China

Moderators: Jillin ChenKi Bae Seung

Discussants: Ng Swee ChoonLatchumana DhasTed FeldmanMujeeb-Ul-HaqUpendra KaulSang Hoon LeeJeong Euy ParkAlan C. Yeung

Operators: Runlin GaoHaibo LiuShubin QiaoXuewan QinYongjian WuYuejin Yang

TUTORIAL AUDITORIUMHow to - What toMugunghwa Hall 1, Sheraton GrandeWalkerhill Seoul Hotel,Level 1, 11:00 AM ~ 6:30 PM

State of the Art Lectures 1

Moderator: Byung-Hee Oh

11:00 AM The Innovation Revolution:Next Generation DESSystemsMartin B. Leon

11:15 AM Advanced Tips, Tricks, andPhilosophies forApproaching DifficultLesions - A JapanesePerspectiveHideo Tamai

Live Case Session 1

11:30 AM The Catholic University ofKorea, St. Mary's Hospital,Seoul, Korea

Moderators: Martin B. LeonJean Fajadet

Discussants: Young-Keun AhnIn-Ho ChaeJei Kun ChaiSameer Indravadan DaniGerald DorrosShu Kin LiSunao NakamuraMitsuyasu Terashima

Operators: Eberhard Grube Ki Bae Seung

12:30 PM Lunchtime ActivitiesPlease refer to page 15


Moderator: Won-Heum Shim

3:30 PM Peripheral VascularInterventions: What IsPossible in 2005 ?Gerald Dorros

3:45 PM Renal Stenting: ASPIRE II , Update onResist and CORAL TrialStatusKrishna Rocha-Singh

Live Case Session 5

4:00 PM San Raffaele Hospital,Milano, Italy

Moderators: Gregg W. StoneJean Fajadet

Discussants: Paul ChenDavid R. Holmes, JrI Chang HsiehChong-Jin KimYoung Dae KimMeilin LiuGary S. MintzSeung-Jung ParkTakehiro YamashitaShu Yang Zhang

Operators: Flavio AiroldiMauro CarlinoAntonio ColomboMatteo MontorfanoGiuseppe Sangiorgi

5:40 PM Featured Lecture : A BriefStatus Update on REALITY(CYPHER vs TAXUS inComplex Lesions)Antonio Colombo

6:00 PM Adjourn

Abo

ut C

VRF


Invi

ted

Facu

lty

Mee

ting

at a

Gla

nce

Con

tent

sFo

cus

Pro

gram

Abs

trac

tLa

y-O

utO

ffic

ial A

bstr

act G

rade

rs

VULNERABLE PLAQUE;How to detect, How to treat

4:00 PM~6:30 PMModerators: Ik-Kyung Jang

Richard E. Kuntz

4:00 PM Erosion, IntraplaqueHemorrhage: The OtherFace of VulnerabilityRenu Virmani

4:15 PM Characterization ofCoronary AtheroscleroticPlaques Using CTAKoen Nieman

4:30 PM Structural and MolecularMagnetic ResonanceImaging of High-RiskAtherosclerosisFarouc Jaffer

4:45 PM Imaging InflamedAtherosclerotic Plaqueswith Positron EmissionTomography Ahmed Tawakol

5:00 PM Coronary ArteryThermographyChristodoulos Stefanadis

5:15 PM Detection and Treatmentof Thin Fibrous Cap, LipidRich, and InflammatoryVulnerable Plaque -Angioscopic EvaluationKyoichi Mizuno

5:30 PM Intravascular ImagingModalities for Detection ofVulnerable Plaque:IVUS, MR, and OCTIk-Kyung Jang

5:45 PM Epidemiologic Stent -Based Approach toVulnerable PlaqueStabilization Based onStatistical Modeling ofPlaque Rupture and DeathRichard E. Kuntz

14/15 _ Program

Program_Friday, April 29

7:30 AM Does Distal ProtectionReduce Infarct Size DuringPrimary Angioplasty?:MRI StudyHyeon-Cheol Gwon

7:40 AM Multivessel versus Single-vessel Angioplasty DuringAcute MIMun Kyung Hong

7:50 AM Case Presenters:Young Joon HongTakehiro Yamashita

#4. Chronic Total Occlusions Mugunghwa Room 4, Level 1

Moderators: James R. MargolisKazuaki Mitsudo

7:00 AM IVUS Guided WireCrossing for CTOTakahiko Suzuki

7:10 AM PCI for CTOKazuaki Mitsudo

7:20 AM Coated vs Non-CoatedWires for CTOJames R. Margolis

7:30 AM Long Term Result ofCypher Stenting in CTOHweung Kon Hwang

7:40 AM Case Presenters:Nakul SinhaYi-Heng LiJoy M Thomas

#5. Complex PCICalla Room, Level 1

Moderators: Ashok SethKi Bae Seung

7:00 AM Drug Eluting Stents inOstial LesionsKenneth Chin

7:10 AM SVG InterventionsAshok Seth

7:20 AM Cypher - LAD OstialLesions; No More Surgery !Ki Bae Seung

7:30 AM Case Presenters:Balbir SinghPramod JaiswalAnil Dhall

LUNCHTIME ACTIVITIESSheraton Grande Walkerhill Seoul Hotel,12:30 PM-2:00 PM

1_AngiomyogenesisCalla Room, Level 1

Sponsored by Clinical Research Center forIschemic Heart disease, The Korea Ministryof Health and Welfare

Moderator: Hyo-Soo Kim

12:30 PM Opening RemarkHyo-Soo Kim

12:35 PM Stem Cell Biology forVasculogenesisTakayuki Asahara

1:00 PM Novel Modulators ofProgenitor CellMobilizationKenneth Walsh

1:25 PM Angiogenesis Mediated byAdipose-Derived StromalCells: How Fat Can BeGoodKeith L. March

1:50 PM Q&A

2_Current Standards and ProposedDirections in PharmacologicApproaches for PCITutorial Auditorium, Level 1

Sponsored by Bristol-Myers Squibb Company

Moderators: Gregg W StoneSeung-Jea Tahk


12:35 PM Metabolic Syndrome,Acute Coronary Syndromeand Adipocytokines / Q&A Tohru Funahashi

1:00 PM The Future of Clopidogrel,and New ClinicalImplications for theManagement of ACSPatients / Q&APatrick Joseph Commerford

1:25 PM Recent Developments inthe Management of AcuteMI Patients / Q&ACharles Inman Wilmer

1:50 PM Closing Remark

#2. Drug Eluting Stent Summit -II Tutorial Auditorium, Level 1

Moderators: Eberhard GrubeYean-Teng Lim

7:00 AM DES for Bifurcation LesionYean-Teng Lim

7:10 AM Final QCA and 3D-IVUSResults From a FIMExperience Using anAngiopeptin PC-CoatedStentVincent On-Hing Kwok

7:20 AM DES for Complex PatientsSubsets Alexandre Abizaid

7:30 AM Everolimus Drug-ElutingStents I: Review of GuidantFUTURE I and II, andStatus Update of FUTUREIII and IVEberhard Grube

7:40 AM ZoMaxx: Abbott's DrugEluting Stent ProgramJohn Ormiston

7:50 AM Case Presenters:Hyun Sook KimYoung Joon Hong

#3. Acute Myocardial InfarctionCosmos Room, Level 3

Moderators: Gregg W. StoneToshiya Muramatsu

7:00 AM EMERALD Trial: LessonsLearned Gregg W. Stone

7:10 AM Final Results ofASPARAGAS StudyToshiya Muramatsu

7:20 AM Coronary Flow Pattern andMyocardial Viability:Comparison with PETSeung-Jea Tahk

6:00 PM Regional PhotodynamicTherapy for VulnerablePlaque Stabilization I:Antrin Alan C. Yeung

6:15 PM Preventing and ArrestingAtherosclerosis;Preventing and ArrestingCoronary AtherosclerosisWilliam C. Roberts

6:30 PM Adjourn

Breakfast Meetings

Meet the Experts:Mini-Lectures and CaseDiscussionsSheraton Grande Walkerhill Seoul Hotel7:00 AM-8:20 AM

#1. Bifurcation LesionsArt Room, Level 4

Moderators: Maurice BuchbinderJunbo Ge

7:00 AM Bifurcation Stent DesignesI: Results With the ASTPetal StentMaurice Buchbinder

7:10 AM Bench Insights intoBifurcation StentingStrategies. An UpdateJohn Ormiston

7:20 AM Efficacy of FX MinirailBalloon in BifurcationLesionsJunbo Ge

7:30 AM PCI for Bifurcation in LMTTakahiko Suzuki

7:40 AM Case Presenters:Seung-Whan LeeDeuk-Young NahNaoto Inoue

Abo

ut C

VRF


Invi

ted

Facu

lty

Mee

ting

at a

Gla

nce

Con

tent

sFo

cus

Pro

gram

Abs

trac

tLa

y-O

utO

ffic

ial A

bstr

act G

rade

rs

3_Lipid Management: A New Era in The Treatment ofCoronary Artery DiseaseMugunghwa Room 4, Level 1

Sponsored by Pfizer Pharmaceuticals KoreaLtd.

Moderator: Wook-Sung Chung

12:30 PM Welcome AddressWook-Sung Chung

12:40 PM The TNT Trial: Is It Time toShift Our Goals in ClinicalPracticeDavid Colquhoun

1:00 PM Early Statin Therapy inAcute Coronary SyndromeCheol-Whan Lee

1:20 PM Beyond the Statin Therapy:The Importance of HDLCholesterolKi Hoon Han

1:40 PM Q & A

4_Drug Eluting Stent Summit - IIICosmos Room, Level 3

Sponsored by CVRF

Moderators: Gian Battista DanziSeong-Wook Park

12:30 PM Update on Jupiter I and IIClinical Trials with theSorin CarbostentTacrocimus Eluting StentGian Battista Danzi

12:45 PM Drug-ElutingBiodegradable Igaki-Tamai StentHideo Tamai

1:00 PM Update on the Endeavor I-V Trials: The Latest Results Ian T. Meredith

1:15 PM Terumo DES Program-Nobori 1 Clinical Trial-Hidehiko Honda

16/17 _ Program

Program_Saturday,April 30

SATURDAY,APRIL 30

7:00 AM Breakfast Meetings Please refer to page 18-19

MAIN ARENAVista Hall, W-Hotel,Level B2, 8:30 AM~3:45 PM

Live Case Session 6

8:30 AM Toyohashi Heart Center,Japan

9:00 AM Asan Medical Center,Seoul, KoreaCoronary

Cases #9, #10, #11

10:00 AM Pusan National UniversityHospital, Pusan, Korea


Discussants: Yaron AlmagorWook-Sung ChungLuyue GaiMoo Hyun KimTien-Hai Koh Kenneth Ka-Hing LamJames R. MargolisHideo TamaiChiung-Jen WuJunghan Yoon

Toyohashi Heart Center,Japan

Operators: Mariko EharaOsamu KatohTetsuo MatsubaraTakahiko SuzukiMitsuyasu TerashimaEtsuo Tsuckikane


Operators: In-Ho ChaeCharlse ChanMyung-Ho Jeong Takeshi KimuraJoo-Young YangAlan C. Yeung


Pusan National UniversityHospital, Pusan, Korea

Operators: Taeg Jong HongJun Hong KimShigeru Saito


Moderator: Seung-Jung Park

10:30 AM Evidence-Based MedicineAnalysis of Current DESClinical Use Guidelines: ARoadmap for CliniciansGregg W. Stone

10:45 AM Plaque Progression andRegressionJames R. Margolis

Live Case Session 7

11:00 AM Asan Medical Center,Seoul, Korea

Live Cases #12, #13, #14

Moderators: Giancarlo BiaminoKrishna Rocha-Singh

Discussants: Chien-Ming HuangYoung Jo Kim Seung-Hwan LeeKazuaki MitsudoS.S. RameshMohd Ali RosliAshok SethWon-Heum ShimUdayachalerm Wasan Tetsu Yamaguchi

1:30 PM Optimizing Outcomes ofPrimary PCI: FromCADILLAC to HORIZONSGregg W. Stone

5_“Reducing Cardiovascular Risk”-Keyword in ManagingHypertension and LipidArt Room, Level 4

Sponsored by MSD KOREA LTD.

Moderator: William C. Roberts

12:30 PM Welcome address

12:40 PM Mechanisms LinkingAngiotensin II &AtherogenesisCarlos M. Ferrario

1:00 PM The Rationale forAngiotensin II ReceptorBlockers (ARBs) in HumanHypertension:Based on Correction ofArterial Remodeling andEndothelial DysfunctionJeong Bae Park

1:20 PM Reducing CardiovascularRisk Through IntensiveLipid Lowering Therapy:Lower is Better ThroughDual Inhibition William C. Roberts

1:40 PM Q & A

Operators: Giancarlo BiaminoJean FajadetMyeong-Ki HongSeong-Wook ParkDae Chul SuhEtsuo Tsuchikane



Moderator: Dong Joo Oh

12:00 PM What Are the Proper EndPoints for DES Trials?Alan C. Yeung

12:15 PM Drug-eluting Stents, LateLoss, and Restenosis DESto Prevent MIsRichard E. Kuntz

12:30 PM Lunchtime ActivitiesPlease refer to page 19-20

EUROPCR SESSIONLive Case Session 8

2:00 PM Asan Medical Center,Seoul, KoreaLive Cases #15, #16, #17

Moderators: Jean FajadetEric Eeckhout

Discussants: Wacin BuddhariGian Battista DanziHyeon-Cheol GwonDavid R. Holmes, JrVincent On-Hing KwokMotomaru MasutaniHun Sik ParkIn-Whan SeongMarc SilvestriTak-Fu Tse

Operators: Dong Hoon ChoiMyeong-Ki HongPaul Hsien-Li KaoSeong-Wook ParkSeung-Jung ParkSeung-Jea Tahk

Abo

ut C

VRF


Invi

ted

Facu

lty

Mee

ting

at a

Gla

nce

Con

tent

sFo

cus

Pro

gram

Abs

trac

tLa

y-O

utO

ffic

ial A

bstr

act G

rade

rs

18/19 _ Program



Moderator: Jean FajadetEric Eeckhout

3:00 PM Lessons Learnt in theComplication Sessions atEuroPCR 2004Eric Eeckhout

3:15 PM Lessons Learnt DuringLive Cases Transmissionsat EuroPCR 2004Jean Fajadet

3:30 PM The Future Role of theCardiologist inExtracardiac Intervention:Carotid and Renal ArteriesGiancarlo Biamino

3:45 PM Clinical Relevance of StentFractures in theTreatment of SFA Lesion:the FESTO StudyGiancarlo Biamino

TUTORIAL AUDITORIUMHow to - What toMugunghwa Hall 1, Sheraton GrandeWalkerhill Seoul Hotel,Level 1, 8:30 AM ~ 12:30 PM


Moderator: Seong-Wook Park

8:30 AM Zen Philosophy- The KEY to CTO SuccessGregg W. Stone

8:45 AM Long Term Outcome of1,000 CTO CasesToshiya Muramatsu

9:00 AM New Concept and Devicefor Ostial and BifurcationStentingYaron Almagor

#7. Drug Eluting Stent Summit - IV Tutorial Auditorium, Level 1

Moderators: Alan C. YeungMathew Samuel Kalarickal

7:00 AM ABT 578 Drug-ElutingStents II: PreclinicalObservations and theClinical Trial Strategy forthe Abbott ZOMAXX StentAlan C. Yeung

7:10 AM Reopro Eluting Stents inAcute Coronary SyndromeMyung-Ho Jeong

7:20 AM DES in Diffuse Long DiseaseMathew Samuel Kalarickal

7:30 AM Cypher PK study in JapanMasato Nakamura

7:40 AM Case Presenters:Pum Joon KimYun-dai Chen

#8. Management of Complications Mugunghwa Room 4, Level 1

Moderators: Ik-Kyung JangMark Simmonds

7:00 AM Heparin InducedThrombocytopenia:Prevalence and ClinicalSignificanceIk-Kyung Jang

7:10 AM Treatment for No ReflowMark Simmonds

7:20 AM Coronary Artery PerforationsJames R. Margolis

7:30 AM Bail-outYasushi Asakura

7:40 AM Transcatheter Closure ofPost Acute MyocardialInfarction VentricularSeptal Rupture: Issuesand ControversiesAjit Sankardas Mullasari

7:50 AM Case Presenters:Honin KanayaSatoru Sumitsuji

#9. IVUS, OCT, Thrombectomy,Atherectomy, and Cutting

Cosmos Room, Level 3

Moderators: Wai Kwang ChanEtsuo Tsuchikane

7:00 AM IVUS Guide PCI at AcuteCoronary SyndromeMotomaru Masutani

7:10 AM Arterial Plaque EvaluationUsing OCT:A Comparison with IVUSand Histological FindingsTakashi Akasaka

7:20 AM Role of Thrombectomy inAcute Infarct AngioplastyWai Kwong Chan

7:30 AM The Role of AtherectomyDevices in the Real DESEraEtsuo Tsuchikane

7:40 AM Case Presenters:Shuvo DuttaBon-Kwon Koo

#10. Peripheral Lesions Calla Room, Level 1

Moderators: Giancarlo BiaminoSeong-Wook Park

7:00 AM Trans-Radial ApproachRenal StentingChiung-Jen Wu

7:10 AM The Upsurge in RenalRevascularization:Cosmetic or ClinicallyRelevant?Giancarlo Biamino

7:20 AM Carotid Angioplasty is thetreatment of Choice forObstructive CarotidBifurcation DiseaseGerald Dorros

7:30 AM Case Presenters:Ma OstovanMasamichi WadaJayesh S. Prajapati

LUNCHTIME ACTIVITIESSheraton Grande Walkerhill Seoul Hotel,12:30 PM-2:00 PM

6_Why not TRI ? Cosmos Room, Level 3

Sponsored by CVRF

Moderators: Saeko TakahashiJunghan Yoon

12:30 PM TRI for Complex LesionMotomaru Masutani

12:45 PM Why not TRI in AcuteCoronary SyndromeJunghan Yoon

1:00 PM Trans-radial Interventionfor Chronic Total OcclusionTakaaki Shiono

1:15 PM Changes in the Diameterof the Radial Artery AfterTRA or TRIYoshifumi Kan

1:30 PM Results of Radial ArteryIntervention in 11,000Patients: A 10-YearExperienceJean Fajadet

1:45 PM TRI for Acute MyocardialInfarction in Kyoto, Reportfrom the Registration ofKyoto AMI ConferenceTakashi Okada

7_Promise of GlitazoneTutorial Auditorium, Level 1

Sponsored by GlaxoSmithKline Korea

Moderator: Byung-Hee Oh

12:30 PM Opening RemarkByung-Hee Oh

12:35 PM Inflammation: NovelTarget for CardiovascularRisk ReductionAndrew Zalewski

9:15 AM SVG Interventions: The Good, The Bad,The Ugly

David R. Holmes, Jr

Live Case Session 3

9:30 AM Toyohashi Heart Center,Aichi, Japan

Moderators: Etsuo TsuchikaneSeung-Jea Tahk

Discussants: Suman Bhandari David Sai-Wah HoDuncan Hung Kwong HoHweung Kon HwangKeiichi IgarashiRichard E. KuntzSang Wook LimShuzheng Lu

Operators: Mariko EharaOsamu KatohTetsuo MatsubaraTakahiko SuzukiMitsuyasu TerashimaEtsuo Tsuckikane


Moderator: Seung-Jea Tahk

10:30 AM Cardiorenal Disease:Profile of Cardiac Patientswith Renal Artery StenosisAnthony Fung

10:45 AM Inoue Stent-Graft Treatmentfor Aortic AneurysmTakeshi Kimura

Live Case Session 4

11:00 AM Pusan National UniversityHospital, Pusan, Korea

Moderators: Mun Kyung HongHideaki Sakai

Discussants: Taehoon AhnKam Tim ChanChiayu ChouSimon Liang ChowJuey-Jen Jim Hwang

Saeko Takahashi Nguyen Quang TuanJoo-Young Yang

Operators: Taeg Jong HongJun Hong KimShigeru Saito


Moderator: Yean-Leng Lim

12:00 PM PercutaneousInterventions for PatentForamen OvaleEric Eeckhout

12:15 PM Left Atrial AppendageExclusion in Patients withAtrial FibrillationDavid R. Holmes

Breakfast Meetings

Meet the Experts :Mini-Lectures and CaseDiscussions Sheraton Grande Walkerhill Seoul Hotel7:00 AM-8:20 AM

#6. Left Main Lesions Art Room, Level 4

Moderators: Seung-Jung ParkHideo Tamai

7:00 AM Medium Term Follow-upof Drug-Eluting Stents inLeft Main BifurcationStenosisTeguh Santoso

7:10 AM Management of Non-Protected Left MainBifurcation Without DESMasahiko Ochiai

7:20 AM LM stenting -CypherSeung-Jung Park

7:30 AM LM stenting -TAXUSMarc Silvestri

7:40 AM Case Presenters:Jae-Hwan LeeJung-Ho Heo


Abo

ut C

VRF

Angioplasty Summit 2005-TCT Asia Pacific would like to extend our deepest appreciation to the official abstract graders.The lavish contributions of their time and expertise permit the educational value of our meeting to uplift one step.

Official Abstract Graders_

Alexandre Abizaid, MDInstituto Dante Pazzanese of Cardiologia, Brazil

Maurice Buchbinder, MDFoundation for Cardiovascular Medicine, USA

In-Ho Chae, MDSeoul National University Hospital, Korea

Kenneth Chin, MDPantai Medical Centre, Malaysia

Antonio Colombo, MDColumbus Hospital, Italy

Jean Fajadet, MDCardiologie interventionelle Clinique Pasteur,France

Junbo Ge, MDZhongshan Hospital, China

Eberhard Grube, MDHeart Center Siegburg, Germany

Hyeon-Cheol Gwon, MDSamsung Medical Center, Korea

Yaling Han, MDShenyang Northern Hospital, China

Mun Kyung Hong, MDNew York Presbyterian Hospital, USA

Myeong-Ki Hong, MDAsan Medical Center, Korea

Jui-Sung Hung, MDChina Medical University Hospital, Taiwan

Yong Huo, MDFirst Hospital Peking University, China

Ik-Kyung Jang, MD Massachusetts General Hospital, USA

Yang-Soo Jang, MDYonsei University Severance Hospital, Korea

Myung-Ho Jeong, MDChonnam National University Hospital, Korea

Paul Hsien-Li Kao, MDNational Taiwan University Hospital, Taiwan

Osamu Katoh, MD, Toyohashi Heart Center, Japan

Hyo-Soo Kim, MDSeoul National University Hospital, Korea

Jae-Joong Kim, MDAsan Medical Center, Korea

Young-Hak Kim, MDAsan Medical Center, Korea

Takeshi Kimura, MDKyoto University Hospital, Japan

Jae-Ki Ko, MDChonbuk National University Hospital, Korea

John R. Laird, MDWashington Cardiology Center, USA

Cheol-Whan Lee, MDAsan Medical Center, Korea

Sang Hoon Lee, MDSamsung Medical Center, Korea

Martin B. Leon, MDColumbia University Medical Center, USA

Yean-Leng Lim, MDThe University of Melbourne, Australia

Jean Marco, MDCardiologie interventionelle Clinique Pasteur,France

Gary S. Mintz, MDCardiovascular Research Foundation, USA

Kazuaki Mitsudo, MDKurashiki Central Hospital, Japan

Toshiya Muramatsu, MDKawasaki Social Insurance Hospital, Japan

Masahiko Ochiai, MDShowa University Hokubu Hospital, Japan

Byung-Hee Oh, MDSeoul National University Hospital, Korea

John A. Ormiston, MDMercy Hospital, New Zealand

Seong-Wook Park, MDAsan Medical Center, Korea

Seung-Jung Park, MDAsan Medical Center, Korea

Shigeru Saito, MDShonan Kamakura General Hospital, Japan

Teguh Santoso, MDUniversity of Indonesia Medical School,Indonesia

Ashok Seth, MDMax Devki Devi Heart & Vascular Institute, India

Ki Bae Seung, MDThe Catholic University of Korea, St. Mary'sHospital, Korea

Takahiko Suzuki, MDToyohashi Heart Center, Japan

Seung-Jea Tahk, MDAjou University Medical Center, Korea

Hideo Tamai, MDShiga Medical Center for Adults, Japan

Etsuo Tsuchikane, MDToyohashi Heart Center, Japan

Tetsu Yamaguchi, MDToranomon Hospital, Japan

Alan C. Yeung, MDStanford University Medical Center, USA

Junghan Yoon, MDYonsei University Wonju Christian Hospital,Korea

Robaayah Zambahari, MDNational Heart Institute, Malaysia


Invi

ted

Facu

lty

Mee

ting

at a

Gla

nce

Con

tent

sFo

cus

Pro

gram

Abs

trac

tLa

y-O

utO

ffic

ial A

bstr

act G

rade

rs

20/21_ Program/Official Abstract Graders

1:00 PM The Promise of theThiazolidinediones in theManagement of Type 2Diabetes-AssociatedCardiovascular DiseaseStephen Alistair Smith

1:25 PM Preventative Effects ofRosiglitazone onRestenosis after CoronaryStent ImplantationDong Hoon Choi

1:45 PM Q & A

8_Advanced EndovascularTherapy: Cordis Clinical Resultson Renal and SFA Stenting Art Room, Level 4

Sponsored by Johnson & Johnson MedicalKorea Ltd.

Moderator: Seong-Wook Park

12:30 PM Opening RemarkSeong-Wook Park

12:40 PM Renal Stenting: ASPIRE II ,Update on Resist andCORAL Trial StatusKrishna Rocha-Singh

1:00 PM Asian Perspective-Takayasu Disease andRenal StentingMohd Ali Rosli

1:20 PM SFA Stenting: BLASTERStudyKrishna Rocha-Singh

1:40 PM Panel Discussion and Q & A

9_Oral Abstract Session"The Best Abstract Presentations"Mugunghwa Room 4, Level 1

Sponsored by CVRF

Moderators: Alan C. YeungKi Bae Seung

12:30 PM Effectiveness of thePercuSurge DistalEmbolic Protection Deviceof High Risk Cases ofAcute MyocardialInfarction by IntravenousUltrasound Analyses:Data from the JapaneseASPARAGUS TrialYoshiaki Ito

12:45 PM Correlation of In VivoIntravascular UltrasoundRadiofrequency DataAnalysis with In VitroHistopathology in HumanCoronary AtherosclesoticPlaques (VH-DCA JapanTrial)Kenya Nasu

1:00 PM Impact of Stent Length as aPredictor of Restenosis inthe Era of Drug-Eluting StentDuk Woo Park

1:15 PM Clinical and AngiographicOutcome afterImplantation of Drug-Eluting Stents inBifurcation Lesions withthe Crush Stent TechniqueLei Ge

1:30 PM Drug-Eluting Stenting isSuperior to Bare-MetalStenting in SaphenousVein GraftsMichael S. Lee

1:45 PM Left Atrial AppendageOcclusion to Prevent Strokein Suboptimal WarfarinCandidates: InterimResults of the EuropeanMulticenter Registry TrialYves Bayard

8TH ANNUALCONFERENCE FORCARDIOVASCULARNURSE &TECHNOLOGISTorganized by CardiovascularTechnology Association(CTA)

MAIN ARENAVista Hall, W-HotelLevel B2, 4:00 PM~5:30 PM

4:00 PM Welcome RemarkSeung-Jung Park

4:05 PM Detection of VulnerablePlaque BurdenSang Gon Lee

4:30 PM Basic Concept of IschemicHeart DiseaseJae-Hwan Lee

5:00 PM Management of STElevation MyocardialInfarction Hyun Sook Kim


Abo

ut C

VRF


Invi

ted

Facu

lty

Mee

ting

at a

Gla

nce

Con

tent

sFo

cus

Pro

gram

Abs

trac

tLa

y-O

utO

ffic

ial A

bstr

act G

rade

rs

22/23_ Oral Abstract Presentations/Poster Abstract Presentations

Poster Abstract Presentations_Angioplasty Summit 2005-TCT Asia PacificPlace: Exhibit Hall, Level B1Date & Time: #1. Friday, April 29, 2005, 9:00~11:00 AM

#2. Friday, April 29, 2005, 2:00~4:00 PM#3. Saturday, April 30, 2005, 9:00~11:00 AM

MODERATEDPOSTERABSTRACTPRESENTATIONS

These presentations, moderated by world-celebratedexperts, will honor 4 or 5 bestabstracts during each poster abstractpresentation session.

#1. Friday, April 29, 2005, 9:00~11:00 AM

(Abstract nos. 7~9, 43)

Moderator: Junbo Ge, MD

#2. Friday, April 29, 2005, 2:00~4:00 PM

(Abstract nos. 72~75, 124)

Moderator: Hideo Tamai, MD

#3. Saturday, April 30, 2005, 9:00~11:00 AM

(Abstract nos. 140, 175, 184, 188, 198)

Moderator: Yeng-Leng Lim, MD

ACUTEMYOCARDIALINFARCTIONFriday, April 29, 2005, 9:00~11:00 AM

(Abstract nos. 7~30)

AS-7. Influence of Patency of the Infarct-Related Artery Before CoronaryIntervention on Myocardial Salvage inPatients with Acute MyocardialInfarction

W. Cui1, M. Sarai2 , T. Kondo2 , T. Sato2, K. Oshima2 , H. Naruse2 , J. Ishii2 , Y. Mori2, H. Hishida2

The Second Hospital of Hebei MedicalUniversity, Shijiazhuang, China1, Division ofCardiology, Department of InternalMedicine, Fujita Health University, Toyoake,Japan2

AS-8. Effectiveness of Thrombectomyand Distal Protection for Non-ST-Segment Elevation MyocardialInfarction

Y. Furuse, T. Muramatsu, R. Tsukahara, Y. Ito,K. Hirano, S. Nishimura, T. Tsubota

Division of Cardiology, Kawasaki SocialInsurance Hospital, Kawasaki, Japan

AS-9. Long-Term Results of Drug-Eluting Stents Compared with Bare-Metal Stents in Patients with AcuteMyocardial Infarction

Y-S. Lee, S-H. Lee, C-W. Nam, S-W. Han, S-H. Hur, Y-N. Kim, K-S. Kim, K-B. Kim

Division of Cardiology, Dongsan MedicalCenter, Keimyung University, Daegu, Korea

AS-10. Radial Access in AcuteMyocardial Infraction: Single-CenterExperience After 7 Years

J.Gaspar, B. Erramun, C. Pardinas, D. Fiandra, A. Fiandra, A. Firszt, J. Musetti, S. Lopez, F. Urrutia

Instituto Nacional de Cirugia Cardiaca,Montevideo, Uruguay

AS-11. Clinical Outcomes of ModernPrimary Angioplasty for AcuteMyocardial Infarction During “Office”Hours Versus “Off” HoursC.Y.Soon1, W.X. Chan1 , Y.J. Wu2 , H.C. Tan1

National University Hospital Singapore1 ,Clinical Trial Epidemiological ResearchUnit, Singapore2

AS-12. Short-term Clinical Outcomes ofPrimary Percutaneous CoronaryIntervention In 214 Patients with AcuteMyocardial Infarction

W.Wei1, G.P.Li1 , Y.M.Xu1 ,S.T.Chen1 ,H.L.Cong1 ,Y.X.Gao1 ,T.G.Huang1

Department of Cardiology, 2nd Hospital ofTianJin Medical University, TianJin, China1

AS-13. Predictive Factors of MajorAdverse Cardiac Events in AcuteMyocardial Infarction PatientsComplicated by Cardiogenic ShockUnderwent Primary PercutaneousCoronary Intervention

S.Y. Lim, M.H. Jeong, E.H. Bae, W. Kim, J.H.Kim, Y.J. Hong, H.W. Park, D.G. Kang, Y.S.Lee, K.H. Kim, S.H. Lee, K.H. Yun, S.N. Hong, J.G. Cho, Y.K. Ahn, J.C. Park, B.H. Ahn, S.H.Kim, J.C. Kang

Chonnam National University Hospital,Gwang Ju, Korea

AS-14. Complement Factors in AcuteMyocardial Infarction and UnstableAngina

M. Namdari, S. Nadri, M.J .Tarrahi, A.E.Nadimi

Lorestan Medical University, Lorestan, Iran

Oral Abstract Presentations_Angioplasty Summit 2005-TCT Asia PacificSaturday, April 30, 2005 12:30 ~ 2:00 PMMugunghwa Room 4, Level 1 (Abstract nos. 1-6)

ACUTEMYOCARDIALINFARCTIONAS-1. Effectiveness of the PercuSurgeDistal Embolic Protection Device inTreatment of High-Risk Cases of AcuteMyocardial Infarction by IntravenousUltrasound Analyses : Data from theJapanese ASPARAGUS Trial

Y. Ito1, T. Muramatsu1, N.Fuijita2 , M. Saito3,H.Kamiya4

Kasaki Social Insurance Hospital,Kanagawa, Japan1, East-Japan MedicalHospital,Kanagawa, Japan2, Ageo CentralGeneral Hospital, Saitama, Japan3,Japanese Red Cross Nagoya 1st Hospital,Nagoya, Japan4

ATHERECTOMYAS-2. Correlation of In VivoIntravascular UltrasoundRadiofrequency Data Analysis with InVitro Histopathology in HumanCoronary Atherosclesotic Plaques (VH-DCA Japan Trial)

K. Nasu1, O. Katoh1, M.P. Margolis2, E. Tsuchikane1, R. Virmani3 ,D.G. Vince4, Y. Takeda1, T. Matsubara1, T. Suzuki1

The Department of Cardiology, ToyohashiHeart Center, Toyohashi, Aichi, Japan1,Volcano therapeutics, Inc.2 , Department ofCardiovascular Pathology, Armed ForcesInstitute of Pathology3, Department ofBiomedical Engineering, The ClevelandClinic Foundation4

DRUG ELUTING STENTAS-3. Impact of Stent Length as aPredictor of Restenosis in the Era ofthe Drug-Eluting Stent

D-W. Park1, Y-H. Kim1, C.W. Lee1, M-K. Hong1,S-W. Park1,H-C. Gwon2, Y-S. Jang3, M-M. Lee4, B.K. Koo4, D.J. Oh5, K.B. Seung6,S-J. Tahk7, J.H. Yoon8, S-J Park1

Asan Medical Center, Seoul, Korea1,Samsung Medical Center, Seoul, Korea2,Yonsei University Hospital,Seoul, Korea3,Seoul National University Hospital, Seoul,Korea4, Korea University Kuro Hospital,Seoul, Korea5, Catholic University Hospitalof Korea, Seoul, Korea6, Ajou UniversityHospital, Suwan, Korea 7, Yonsei UniversityWonju Hospital, Seoul, Korea8

AS-4. Clinical and AngiographicOutcome After Implantation of Drug-Eluting Stents in Bifurcation Lesionswith the Crush Stent Technique

L. Ge1, I. Iakovou2 , J. Cosgrave2 , G.M. Sangiorg2 , F. Airoldi2 ,M. Montorfano2, I. Michev 2 , A. Chieffo2 , M. Carlino2 , N. Corvaja2 , J. Ge1, A. Colombo2

Department of Cardiology, ZhongshanHospital, Fudan University, Shanghai,China1 , EMO Centro Cuore Columbus andSan Raffaele Hospital, Milan, Italy2

AS-5. Drug-Eluting Stenting is Superiorto Bare-Metal Stenting in SaphenousVein Grafts

M.S. Lee, A.P. Shah, A. Jamali, S. Kar, S. Dohad, J. Aragon, R.R. Makkar

Cedars-Sinai Medical Center, Los Angeles,CA, USA

NONCORONARYCARDIACINTERVENTIONAS-6. Left Atrial Appendage Occlusionto Prevent Stroke in SuboptimalWarfarin Candidates: Interim Resultsof the European Multicenter RegistryTrial

Y. Bayard1, H. Omran2, L. Thuesen3, M. Pichler4,E. Rowland5, A. Bartorelli6 , P. Brugada7, P. W. Serruys 8, W. Budts9 , A. Ramondo10 , A. Vahanian11, P. Probst12, G. Montalescot13,J. F. Piechaud14, K. H. Kuck15, W. Ruzyllov16, J. Marco17, T. Wichter18, E. Garcia19, E. Onorato20,E. Fischer1 , M. Leetz1, S. Ostermayer1 , H. Lissman-Jensen1 , K. Lang1 , H. Sievert1

CardioVascular Center Frankfurt, SanktKatharinen, Frankfurt, Germany1, St. MarienKrankenhaus Bonn, Bonn, Germany2, SkejbySygehus, Aarhus, Denmark3,Landeskrankenhaus Salzburg, Salzburg,Austria4, St Georges Hospital, London,United Kungdom5, Centro CardiologicoS.p.A., Milan, Italy6, O.L. Vrouwziekenhuis,Aalst, Belgium7, Hartcentrum Rotterdam,Rotterdam, Netherlands8, UZ Gasthuisberg,Leuven, Belgium9, Azienda Ospedaliera diPadova, Padova, Italy10, Groupe HospitalierBichat, Paris, France11, AllgemeinesKrankenhaus Vienna, Vienna, Austria12,Groupe Hospitalier Pitie-Salpetriere, Paris,France13, Institut Cardiovasculaire Paris Sud,Massy, France14, Allgemeines KrankenhausSt. Georg, Hamburg, Germany15, Institute ofCardiology, Warsaw, Poland16, CliniquePasteur, Toulouse, France17,Universitataklinikum Munster, Munster,Germany18, Hospital General Universitario,Madrid, Spain19, Humanitas Gavazzeni,Bergamo, Italy20

Abo

ut C

VRF


Invi

ted

Facu

lty

Mee

ting

at a

Gla

nce

Con

tent

sFo

cus

Pro

gram

Abs

trac

tLa

y-O

utO

ffic

ial A

bstr

act G

rade

rs

24/25_ Poster Abstract Presentations

Poster Abstract Presentations_Angioplasty Summit 2005-TCT Asia Pacific

Department of Cardiology1 and EmergencyMedicine2, Wonju College of Medicine,Yonsei University, Wonju, Korea

AS-30. Impact of Anemia and MildRenal Insufficiency in PatientsUndergoing Direct PercutaneousCoronary Intervention for AcuteCoronary Syndromes

I. hideki, R. Iijima, K. Makino, H. Shinji, H. Hara, T. Tsunoda, M. Nakamura

Toho university Ohashi HospitalDepartment of Cardiovascular Medicine,Tokyo, Japan

ATHERECTOMYFriday, April 29, 2005, 9:00~11:00 AM


AS-31. Long-Term Prognosis ofDirectional Coronary Atherectomy inLesions with Only Ostial Stenosis of theLeft Anterior Descending and LeftCircumflex Coronary Arteries

T. Hirose, H. Mastuo, S. Watanabe, T. Watanabe, S. Warita, T. Kojima, T. Shiraki,M. Iwama, K. Ono, M. Kouda, H. Takahashi, T. Segawa, Y. Mastuno

Department of Cardiology, Gifu PrefecturalHospital, Gifu, Japan

AS-32. Acute and Chronic PhaseResults of FLEXI-CUT DirectionalCoronary Atherectomy in AcuteMyocardial Infarction

K. Oku, Y. Shiraishi, Y. Uchida, H. Tazaki, K-I. Nakahara

Department of Cardiovascular Medicine,National Hospital Organization NagasakiMedical Center, Nagasaki, Japan

BALLOONANGIOPLASTYFriday, April 29, 2005, 9:00~11:00 AM


AS-33. Effects of Constant MagneticField on Apoptosis, Adhesion MoleculeExpression in Endothelial Cells, andTheir Adhesion Rates with Monocytes

H.X. Cheng1 , H.C. Wang1 , K.W. Xu2 , L. Zhou2

Xijing Hospital, Fourth Military MedicalUniversity, Xi’an,Shaanxi China1 , School ofMaterial Science & Engineering, Xi’anJiaotong University, Xi’an, China2

AS-34. Impact of Balloon InflationPressure During Primary CoronaryStenting on Clinical Outcomes inPatients with Acute MyocardialInfarction

Y-K. Cho, S-H. Hur, K-B. Kim, Y-S. Lee, C-W. Nam, S-H. Lee, S-W. Han, K-S. Kim, Y-N. Kim

Cardiovascular Medicine, KeimyungUniversity College of Medicine, Daegu,Korea

AS-35. A Novel Strategy to Obtain aSuccessful Cross of Chronic TotalOcclusions: Intravascular Ultrasound-Guided Wire Crossing

T.Ito, T.Suzuki, T.Matsubara, E.Tsuchikane,H.Sato, M.Ehara, T.Suzuki, Y.Takeda, K.Nasu,A.Murata, R.Kurokawa, Y.Suzuki, K.Sato,O.Katoh

Toyohashi Heart Center, Japan

AS-36. Intracoronary -RadiationCombined with Cutting BalloonAngioplasty for Treatment of In-StentRestenosis

Y. Zhou, D. Qu, W. Liu

Tianjin Xinhua Hospital, Tianjin, China

AS-15. Practice Variation for GuidelinesApplication in Patients with Acute ST-Segment Elevation MyocardialInfarction who Arrived at HospitalsWithin 12 Hours of Onset of Chest Pain

Y. Chen , X. Song, S. Lv, H. Zhu, W. Pan, S. Ning, T. Kang

Capital Medical University Affiliated BeijingAn Zhen Hospital, Beijing , China

AS-16. Clinical Results of IntravascularUltrasound-Guided Distal ProtectionTherapy for Acute Myocardial Infarction

T. Tsubota, T. Muramatsu, R. tsukahara, Y.Ito, K. Hirano, Y. Furuse, S. Nishimura

Division of Cardiology, Kawasaki SocialInsurance Hospital, Kanagawa, Japan

AS-17. A Comparative Study onTransradial Versus Transfemoral ArteryAccess for Primary PercutaneousCoronary Intervention in Patients withAcute Myocardial Infarction

X. Fu, J. Liu, W. Wu, X. Gu, S. Li

The 2nd Hospital of Hebei MedicalUniversity, Shijiazhuang, China

AS-18. Short-Term Outcomes ofSirolimus-Eluting Stent Implantation inPatients with ST- Elevation MyocardialInfarction: Comparison with Bare-Metal Stent Implantation

T-H. Yang, Y-H. Kim, K-M. Park, D-W. Park, K-H. Ko, B-K. Choi, S-H. Lee, Y-H. Jung, K-H. Han, C.W. Lee, M-K. Hong, J-J. Kim,S-W. Park, S-J. Park

Asan Medical Center, University of UlsanCollege of Medicine, Seoul, Korea

AS-19. Distal Protection ReducesInfarct Size After Primary Angioplastyin Acute Myocardial Infarction:Magnetic Resonance Imaging Study

I. Rhee, H-C. Gwon, Y.H. Choe, J.H. Choi, S.H. Lee, K.P. Hong, J.E. Park, J.D. Seo

Cardiac and Vascular Center, SungkyunkwanUniversity School of Medicine, SamsungMedical Center, Seoul, Korea

AS-20. Acute Myocardial Infarctionfrom Left Main Occlusion: ClinicalFinding and Strategy of PercutaneousCoronary Intervention

S-P. Wang, S.P. Wang, Y. Chen, C.C. Fang

Cardiovascular Center, Tainan MunicipalHospital, Tainan, Taiwan

AS-21. Cardiac Magnetic ResonanceImaging in Acute Phase PredictsImprovement of Left VentricularFunction in Chronic Phase in AcuteCoronary Syndrome

S. Miyata, K. Igarashi, J. Furuya, R. Shinohe

Division of Cardiology, Hokkaido SocialInsurance Hospital, Sapporo, Japan

AS-22. Efficacy of ThrombosuctionUsing The Export Aspiration CatheterBefore or During Primary PercutaneousCoronary Intervention in AcuteMyocardial Infarction

W.C. Kang, T.H. Ahn, S.H. Han, E.K. Shin

Cardiology Division, Cardiovascular Center,Gil Hospital, Gachon Medical School,Incheon, Korea

AS-23. Optimal Glycemic Control DoesNot Predict Lesser Occurrence of No-Reflow and Better 30-day Outcomes inPatients with Diabetes UndergoingPrimary Angioplasty for MyocardialInfarction

C.H. LEE, S.G. Teo, E. Hong, H.B. Wong, A. Low, A. Sutandar, H.C. Tan, Y.T. Lim

National University Hospital, Singapore

AS-24. Rate of Distal Embolisation inPrimary Angioplasty in Acute MyocardialInfarction Without Distal EmbolizationPrevention and Thrombectomy DevicesA. Wong, D. Nait, C. Phay, E.H. Ng, C. Chan,T.H. Koh

National Heart Centre, Singapore

AS-25. Primary Percutaneous CoronaryIntervention in the Octogenarian

Y-C. Wang, C-S. Hung, L-C. Lin, T-D. Wang, H-L. Kao, C-L. Chao, C-M. Lee, K-L. Hsu, F-T. Chiang, C-S. Liau, C-D. Tseng, J-J.Hwang

Yun-Lin Branch Hospital, National TaiwanUniversity Hospital, Yun-Lin and Taipei,Taiwan

AS-26. Are Fractional Flow Reserveand Hyperemic Epicardial StenosisResistance Index Useful in AssessingSeverity of Coronary Artery Stenosis inAcute Myocardial Infarction?

T-Y. Choi, S-J. Tahk, M-H. Yoon, S-Y. Choi, B-J. Choi, Z-G. Zheng, G-S. Hwang, J-H. Shin

Department of Cardiology, School ofMedicine, Ajou University, Suwon, Korea

AS-27. Correlation with CoronaryWedge Pressure and Phasic CoronaryFlow Velocity Patterns in AcuteMyocardial Infarction PatientsAccording to Presence or Absence ofAngiographic Collateral Circulation

M-H. Yoon, S-J. Tahk, S-Y. Choi, T-Y. Choi, B-J. Choi, S-G. Ahn, Z-G. Zheng, G-S. Hwang,J-H. Shin

Department of Cardiology, School ofMedicine, Ajou University, Suwon, Korea

AS-28. Does Early Reperfusion Therapywith Primary Percutaneous CoronaryIntervention in Patients with AcuteMyocardial Infarction Decrease MajorAdverse Cardiac Events?

D-Y. Nah1, J.H. Kim1, J-y. Lee1, W-J. Chun1,K.U. Park1, D-U. Lee1

Department of Internal Medicine1 ,Department of Family Medicine2 DonggukUniversity Gyeongju Hospital, Gyeongju, Korea

AS-29. Predictors of Reperfusion-Mediated Cardiogenic Shock DuringPrimary Percutaneous CoronaryIntervention in Inferior ST-SegmentElevation Myocardial Infarction

S-H. Lee1, J-Y. Kim1 , I-H. Jung1 , H-S. Wang1,H-S. Jung1 , B-S. Yoo1, S-O. Hwang2 , J.H.Yoon1, K-H. Choe1

Abo

ut C

VRF


Invi

ted

Facu

lty

Mee

ting

at a

Gla

nce

Con

tent

sFo

cus

Pro

gram

Abs

trac

tLa

y-O

utO

ffic

ial A

bstr

act G

rade

rs



AS-52. New Insight of Cutting BalloonAngioplasty Before Stent Implantationin the Drug-Eluting Stent Era:Serial Volumetric IntravascularUltrasound Analysis

M. Shiba1, M. Nakamura1, M. Wada1, M. Yamamoto1, T. Tsuji1, R. Iijima1, R.Nakajima1, T. Yoshitama1, H. Hara1, T.Tsunoda1, T. Takagi 2

Department of Cardiovascular Medicine,Toho University Ohashi Hospital, Tokyo,Japan1, Department of Internal Medicine,Toshiba Hospital, Tokyo, Japan2

AS-53. Staged Coronary Artery BypassSurgery and Stenting in Patients withLeft Main Coronary Artery Stenoses

I-C. Hsieh1, P-J. Lin2, H-L. Huang1, S-H. Chang1, K-C. Hung1, F-C. Lin1, D. Wu1

Second Section of Cardiology1 , Section ofCardiovascular Surgery2, Chang GungMemorial Hospital, Chang Gung UniversityCollege of Medicine, Taoyuan, Taiwan

AS-54. Transradial Intervention forLeft Main Trunk Disease

T. Shiono, S. Saito, S. Tanaka, Y. Miyashita, S.Takahashi, H. Domae, Y. Taketani, K. Shibuya

Heart center of Shonankamakura GeneralHospital, Kamakura, Japan

AS-55. Long-Term Outcome in ElderlyPatients with Severe Coronary ArteryDisease Following Coronary Stentingon Large Vessels

C.M. Huang1, M.S. Young1 , J.J. Wang1 , M.C. Chiang1 , Y.N. Yang1 , A.N. Feng1 , J. Wei2

Division of Cardiology, Department ofInternal Medicine, Cheng-HsinRehabilitation Medical Center, Taipei,Taiwan, R.O.C.1 , Heart Centre, Cheng HsinRehabilitation Medical Center, Taipei,Taiwan, R.O.C.2

AS-56. Five-Year Outcomes AfterStenting of Unprotected Left MainCoronary Artery Stenosis in Patientswith Normal Left Ventricular Function

S-W. Lee, Y-H.Kim, K-M. Park, K-H. Ko, C.W.Lee, M-K. Hong, J-J. Kim, S-W. Park, S-J.Park

Department of Medicine, Asan MedicalCenter, University of Ulsan College ofMedicine, Seoul, Korea

AS-57. Effects of Stent-Based Deliveryof Rapamycin and Methotrexate onNeointimal Formation in a PorcineCoronary Model

W. Zhao, J. Yao, L. Li

Tianjin PULUOBI Bioengineering TechniqueCo Ltd, Tianjin, China

AS-58. Clinical and AngiographicFactors Associated with the Elevationof Cardiac Troponin-T FollowingCoronary Stenting

J-H. Kang, J-S. Park, J-H. Bae, B-S. Shim, D-G. Shin, G-R. Hong, Y-J. Kim

Yeungnam Univeristy Hospital, Daegu, Korea

AS-59. Clinical and AngiographicOutcome of Drug-Eluting StentImplantation for Treatment of DiffuseLong Lesion: COMATE Registry

B.K. Lee1, B.O. Kim1 , Y-G. Ko2 , Y.W. Yoon3, S.H. Lee 4, K.H. Kwon5 , S.J. Oh6 , S-H. Choi 7

Inje University Sanggyepaik Hospital1,Yonsei University Severance Hospital2,Yongdong Severance Hospital3 , WonjuChristian Hospital4, Ehwa WomansUniversity Mokdong Hospital5 , NHIC IlsanHospital6 , Hallym University KangnamSacred Heart Hospital 7

AS-60. Feasibility of the TransradialApproach in Bifurcation Lesion

H.S. Jung, J-Y. Kim, S-H. Lee, B-S. Yoo, J.H. Yoon, K-H Choe,

Department of Cardiology, Wonju College ofMedicine, Yonsei University, Wonju, Korea

AS-61. P-selectin Expression inCoronary Stenting

Y. Jiang1, H. Wang2 , H-M. Liu3 , H-J. Yu3 , Y-R. Liu2 , H. Zhao1 , W-M. WANG1

Cardiac Catheterization Laboratory1, FlowCytometry Laboratory1, ThrombosisLaboratory3, People’s Hospital, BeijingUniversity, China

AS-62. Clinical Experience of DirectStenting with Sirolimus-Eluting Stents inPatients with Coronary Artery Disease

I. Nazeri, A. Nazeri, S. Shokoufi-Moghiman, K. Hashemy

Tehran Medical University, Nazeri HeartInstitute, Tehran, Iran

AS-63. Initial and Long-Term Results ofElective Percutaneous CoronaryIntervention for the Nonprotected LeftMain Stenosis

H. Araki, M. Ochiai, K. Ashida, N. Ogata, H. Okabayashi, C. Obara

Showa University Northern YokohamaHospital, Kanagawa, Japan

AS-64. Multivessel Intervention inPatients Undergoing PrimaryAngioplasty

A. TripathiV. Sharma,

National Heart Institute, All India HeartFoundation, New Delhi, India

AS-65. Small “y” Stenting Technique of 6Fr Catheter Transradial ApproachIntervention for True BifurcationLesion

Y. Hikichi, S.Hashimoto, D.Fujimatsu,F.Narimatu, K.Node

Saga University School of Medicine, Saga,Japan

CARDIAC IMAGINGFriday, April 29, 2005, 9:00~11:00 AM


AS-37. Relation Between InflammationFactors and the Severity of CoronaryArtery Lesions

Z.G. Ji, H.B. Liu, Y.X. Zhang, K.S. Liu

Cardiovascular Department of The FirstHospital of Hebei Medical University,Shijiazhuang, Hebei Province, PR China

AS-38. Angioscopic Evaluation of theEffects of Adjunctive Low-PressureBalloon Dilatation After CoronaryRotational Atherectomy

A. Ishihara, T. Tanaka, S. Mikura, K. Yano, Y. Shimizu, T. Sada, Y. Kira

Department of Cardiology, Showa GeneralHospital, Tokyo, Japan

AS-39. Contrast-Enhanced Electron-Beam Computed Tomography ProvidesDetailed Characterization of theCoronary Venous System

M.S. Lee, A.P. Shah, J. Friedman, N. Dang, D. Bobo, S. Fariabi, S. Kar, J. Aragon, C. Caraang, D. Berman, R.R. Makkar

Cedars-Sinai Medical Center, Los Angeles,CA , USA

AS-40. Significance of CollateralCirculation in Acute MyocardialInfarction Assessed by CardiacMagnetic Resonance Imaging

J.H. Kim, Y.H. Park, W.S. Ko, W.H. Bae, H.G. Lee,K.J. Chun, T.J. Hong, K.S. Choo, Y.W. Shin

Department of Internal Mediceine, PusanNational University Hospiral, Busan, Korea

AS-41. Infarct Size ReductionsMeasured by Follow-Up ContrastEnhancement Magnetic ResonanceImaging in Acute Myocardial InfarctionPatients

J-Y. Moon1, Y-J. Kim2, S.H. Park1, B.W. Choi2, Y-G. Ko1, Y-S. Jang1, N.S. Chung1, W-H. Shim1,S-Y. Cho1

Division of Cardiology1 , CardiovascularCenter, Rsearch Institute , Division ofRadiology2, Yonsei University College ofMedicine

AS-42. Direct Comparison BetweenNoninvasive Coronary Angiographywith Multislice Spiral ComputedTomography and Conventional InvasiveCoronary Angiography

H-S. Ma1, M.K-Y. Lee1 , C.L. Fu1 , L.Y. Tam1 ,M.C. Chan1 , W.K. Wong2 , M.C. Chan2 , S. Chan2 , S.F. Yiu1 , K.C. Ho1 , C.S. Chiang1

Division of Cardiology, Department ofMedicine1 , Department of DiagnosticRadiology and Imaging2 , Queen ElizabethHospital, Hong Kong SAR.

CORONARY STENTFriday, April 29, 2005, 9:00~11:00 AM


AS-43. Outcomes of Jailed SideBranches After Drug-Eluting StentImplantation: Physiologic Assessmentwith Fractional Flow Reserve

B-K. Koo, H-J. Kang, T-J. Youn, I-H. Chae, D-J. Choi, H-S. Kim, B-H. Oh, Y-B. Park

Seoul National University Hospital, Seoul, Korea

AS-44. D-Dimer, but Not TheParameters of Platelet Activation,Predicts Myocardial Injury After ElectivePercutaneous Coronary Intervention

W. Cui, J.C. Lu, J. Du, Y.M. Hao, F. Liu, Y.J. Li,R.Q. Xie

The Second Hospital of Hebei MedicalUniversity, Hebei , China

AS-45. Transradial Coronary Stentingin Patients 65 Years of Age

C.M. Huang1, M.S. Young1, J.J. Wang1, M.C. Chiang1, Y.N. Yang1, A.N. Feng1, J. Wei2

Division of Cardiology, Department ofInternal Medicine, Cheng-HsinRehabilitation Medical Center, Taipei,Taiwan, R.O.C.1, Heart Centre, Cheng HsinRehabilitation Medical Center, Taipei,Taiwan, R.O.C.2

AS-46. Neurointervention ofIntracranial Atherosclerotic Disease

J.H. Han, C.W. Huh, W.H. Sung, S.T. Gong, S.K. Lee

Myung Ji St. Mary's Hospital, Seoul, Korea

AS-47. The First Experiences with aNew Percutaneous Left-VentricularAssist Device

M. Skowasch1, A. Roemer1 ,K. Lang1 ,H.Sievert1

CardioVascular Center Frankfur and Med.Klinik I Sankt Katharinen Krankenhaus,Frankfurt/Main, Germany1

AS-48. Feasibility of PercutaneousCoronary Intervention via TransulnarArtery Approach in Selective Patientswith Coronary Heart Disease

X. Fu, J. Liu, W. Wu, X. Gu


AS-49. Small-Vessel Stenting inLesions Less Than 15mm with Non-Drug-Eluting Stents

B.R.Shah, S.B. Dalal, J.R. Rawal, S.M. Shah,R.B. Gupta

Sheth V.S.General Hospital, Ahmedabad, India

AS-50. Initial and Late Outcomes withthe Multi-Link Penta Stent

S. Osaki, S. Endoh, K. Yanagihara, F.Kitamura, A. Ohtahara, T. Kasahara

San-in Rosai Hospital, Yonago, Tottori, Japan

AS-51. Safety and Efficacy of BovinePericardium Covered Stent for theTreatment of Saphenous Vein GraftLesions: Initial Experiences

L. Ge1 , I. Iakovou2 , J. Cosgrave2 , G.M. Sangiorg2 , F. Airoldi2 , G. Melzi 2 , M. Montorfano2, I. Michev 2 , A. Chieffo2 , M. Carlino2 , N. Corvaja2 , J. Ge2, A. Colombo2

Department of Cardiology, ZhongshanHospital, Fudan University, Shanghai,China1 , EMO Centro Cuore Columbus andSan Raffaele Hospital, Milan, Italy2

Abo

ut C

VRF


Invi

ted

Facu

lty

Mee

ting

at a

Gla

nce

Con

tent

sFo

cus

Pro

gram

Abs

trac

tLa

y-O

utO

ffic

ial A

bstr

act G

rade

rs



DISTAL EMBOLICPROTECTIONFriday, April 29, 2005, 9:00~11:00 AM


AS-66. Mechanical Distal ProtectionDuring Primary Angioplasty

P. Cervinka, P. Spacek, M. Bystron, M. Kvasnak, M. Behounek, J. Bednarova, J. Herman, J. Veselka

Cardiology Department, Masaryk Hospital,Usti Nad Labem, Czech Republic

AS-67. Effect for Chronic Phase LeftVentricular Ejection Franction UsingAdjunctive Distal Protection DuringPercutaneous Coronary Intervention inPatients with Acute Coronary Syndrome

K. Yoshida, K. Oku, Y. Uchida, Y. Shiraishi, H. Tasaki, K.I. Nakahara

Cardiovascular Division of NagasakiMedical Center, Nagasaki, Japan

AS-68. Role of Protective Devices inPercutaneous Coronary Intervention

C.L. Fu, M.K-Y. Lee, S.L. Li, K.T. Chan, C.S. Chiang

Hong Kong Special Administrative Region,Queen Elizabeth Hospital, Hong Kong

AS-69. Distal Protection During PrimaryPercutaneous Coronary Interevention isAssociated with Delayed Recovery ofMyocardial Perfusion in AcuteMyocardial Intervention Patients

M. Shiba1, M. Nakamura1, M. Wada1, M. Yamamoto1, T. Tsuji1, R. Iijima1, R.Nakajima1, T. Yoshitama1, H. Hara1, T.Tsunoda1, T. Takagi2

Toho University Ohashi HospitalDepartment of Cardiovascular Medicine,Tokyo, Japan1, Toshiba Hospital Departmentof Internal Medicine , Tokyo, Japan2

AS-70. Export Aspiration CatheterThrombosuction Before Actual PrimaryAngioplasty for Acute MyocardialInfarction Procedure

S.Y. Lee, J.H. Doh, J. Namgung, W.R. Lee

Inje University IlsanPaik Hospital Vision21Cardiac & Vascualr Center, Goyang, Korea

AS-71. Prevention of DistalEmbolization During PercutaneousCoronary Intervention in Patients withAcute Coronary Syndrome

J. Zhao, G. Liu, L. Li

Tianjin JINLONGKANG Institute of MedicalScience, Tianjin, China

DRUG ELUTINGSTENTFriday, April 29, 2005, 2:00~4:00 PM


AS-72. No Stent Thrombosis and LowCardiac Events After Abciximab-CoatedStent in Patients with Acute MyocardialInfarction

W. Kim, M.H. Jeong, Y.J. Hong, H.W. Park, G.M. Lee, S.Y. Jeong, I.S. Kim, K.H. Kim, K.H. Yoon, D.K. Kang, S.N. Hong, S.Y. Lim, S.H. Lee, J.H. Kim, Y.K. Ahn, J.G. Cho, J.C. Park, H. Kim, D.L. Cho, J.C. Kang

Chonnam National University Hospital,Gwangju, Korea

AS-73. Drug-Eluting Stents: An 1-year Experience in a SingleTertiary Care Hospital in Taiwan

C-N. Hsu, P. H-L. Kao, F-T. Chiang, J. Chao, C-S. Liau, C-M. Lee, T-D. Wang, K-L. Hsu, L-C. Lin, C-D. Tseng, J-J. Hwang

Division of Cardiology, Department ofInternal Medicine, National TaiwanUniversity Hospital, Taipei, Taiwan

AS-74. A Prospective Randomized Trialof Sirolimus-Eluting Stent ImplantationVersus Coronary Brachytherapy forDiffuse In-Stent Restenosis

S-W. Park1, S-W. Lee1, M-J. Kim1, K-M. Park1,Y-H. Kim1, C.W. Lee1, M-K. Hong1, J-J. Kim1, M-M. Lee1 , B.K. Koo2, S-J. Park1

Departments of Medicine, Asan MedicalCenter, University of Ulsan College ofMedicine, Seoul, Korea1, Seoul NationalUniversity Hospital, Seoul, Korea2

AS-75. Effects of a Nonsoluble LowMolecular Weight Antioxidant onPolymer Biocompatibility in a PorcineCoronary Model

L.L. Gibson1, R.I. Collingwood1, Y. Song2, R. Hermann2, K. Kamath2, J. Barry2, A.J. Carter1

Medical Device Research Laboratory,Borgess Medical Center, Kalamazoo, MI,USA1, Boston Scientific Corporation, Natick,MA, USA2

AS-76. Abciximab-Coated CoronaryStents Inhibits Cell Proliferation andExtracellular Matrix Synthesis

Y.J. Hong, M.H. Jeong, W. Kim, S.Y. Lim, S.H.Lee, S.N. Hong, K.H. Yun, K.H. Kim, D.G.Kang, Y.S. Lee, J.H. Kim, Y.K. Ahn, J.G. Cho,J.C. Park, J.C. Kang


AS-77. Comparison of theRevascularization Methods for In-StentRestenosis: Cutting Balloon,Brachytherapy, and Paclitaxel-andSirolimus-Eluting Stent

J.S. Park1, H.J. Kang1 , Y.S. Cho2, T.J. Youn2 ,W.Y. Chung2 , B.K. Koo1, I.H. Chae2 , D.J. Choi2

, H.S. Kim1 , D.W. Sohn1, B.H. Oh1, M.M. Lee1,Y.B. Park1 , Y.S. Choi1

Seoul National University Hospital, Seoul,Korea1, Seoul National University BundangHospital, Seoul, Korea2

AS-78. Safety and Effectiveness ofOverdilation in Sirolimus-Eluting StentImplantation

K.M. Park, T.H. Yang, B.K. Lee, M.G. Kim, B.R.Choi, K.H. Park, G.H. Ko, Y-H. Kim, C.W. Lee,M-K. Hong, J-J. Kim, S-W. Park, S-J. Park

Asan Medical center, Seoul, Korea

AS-79. Comparison of StentingStratagies for Bifurcation CoronaryLesions: Simple Versus ComplexTechnique with Sirolimus-Eluting Stent

B-K. Lee, Y-H. Kim, M-K. Kim, B-R. Choi, M-J.Kim, K-H. Ko, S-W. Lee, K-H. Han, C.W. Lee,M-K. Hong, J-J. Kim, S-W. Park, S-J. Park

Asan Medical Center, Seoul, Korea

AS-80. Safety and Effectiveness ofSirolimus-Stent Implantation for In-Stent Restenosis at theUnprotected Left Main Coronary Artery

H-S. Kim, Y-H. Kim, B-K. Lee, T-H. Yang, K-H. Ko, M-J. Kim, K-M. Park, S-W. Lee, C.W.Lee, M-K. Hong, J-J. Kim, S-W. Park, S-J. Park

Asan Medical Center, University of UlsanCollege of Medicine, Seoul, Korea

AS-81. Nine-Month Follow-Up Results ofLong Drug-Eluting Stent Study in Korea

S-J. Park1, Y-H. Kim1 , C.W. Lee1 , M-K. Hong1 ,S-W. Park1 , H-C. Gwon2 , Y-S. Jang3 , M. Lee 4,B.K. Koo5, D.J. Oh5, K.B. Seung6 , S-J. Tahk7, J. Yoon8

Asan Medical Center, Seoul, Korea1 ,Samsung Medical Center, Seoul, Korea2 ,Yonsei University Hospital, Seoul, Korea3 ,Seoul National University Hospital, Seoul,Korea4, Korea University Kuro Hospital,Seoul, Korea5, Catholic University Hospitalof Korea, Seoul, Korea6 , Ajou UniversityHospital, Seoul, Korea7 , Yonsei UniversityWonju Hospital, Seoul, Korea8

AS-82. Impact of Diabetes Mellitus onCoronary Restenosis After LongSirolimus-Eluting Stent ImplantationCompared with Long Bare Metal Stent

Y-H. Kim1, C.W. Lee1, M-K. Hong1, S-W. Park1,H-C. Gwon2, Y-S. Jang3, M-M. Lee4, B-K. Koo4,D-J. Oh5, K-B. Seung6, S-J. Tahk 7, J-H. Yoon 8,S-J. Park 1

Asan Medical Center, Seoul, Korea1,Samsung Medical Center, Seoul, Korea2,Yonsei University Hospital, Seoul, Korea3,Seoul National University Hospital, seoul,Korea4, Korea University Kuro Hospital,Kuro, Korea5, Catholic University Hospital,Seoul, Korea6 , Ajou University Hospital,Suwon, Korea7, Yonsei University WonjuHospital, Wonju, Korea8

AS-83. Influence of Overlapping withSirolimis-Eluting Stents on Intimal Growth

J-H. Lee, Y-H. Kim, M-K. Hong, B-K. Lee, D-W. Park, B-R. Choi, K-H. Park, S-W. Lee, K-H. Han, C. W. Lee, J-J. Kim, S-W. Park, S-J. Park

Asan Medical Center, Univeristy of UlsanCollege of Medicine, Seoul, Korea

AS-84. Effectiveness of Complete LesionCoverage with Sirolimus-Eluting Stent forOstial Left Anterior Descending ArteryStenosis Compared with Bare Metal Stent

K-B. Seung1, Y-H. Kim2, P-J. Kim1, W-S. Chung1,S-J. Tahk3, C. W. Lee2, M-K. Hong2, J-J. Kim2, S-W. Park2, S-J. Park2

Catholic University Medical College, Seoul,Korea1 , Asan Medical Center, Seoul,Korea2, Ajou University, Suwon, Korea3

AS-85. Sirolimus-Eluting StentImplantation for Unprotected Left MainCoronary Artery Stenosis: Comparisonwith Bare Metal Stent Implantation

S-J. Park1, Y-H.Kim1 , B-K.Lee1 , S-W.Lee1 ,C.W.Lee1 , M-K.Hong1 , J-J.Kim1 , G.S.Mintz2 ,S-W.Park1

Department of Medicine, University ofUlsan College of Medicine, Asan MedicalCenter, Seoul, Korea1 , CardiovascularResearch Foundation, New York, NY, USA2

AS-86. Use of Drug-Eluting StentsImproves Outcome of PercutaneousCoronary Intervention in Small VesselCoronary Lesions

T. Santoso

Div. of Cardiology, Dept. of InternalMedicine, Univ. of Indonesia Medical School,Medistra Hospital, Jakarta, Indonesia

AS-87. Impact of Diabetes Mellitus onAngiographic Restenosis in the Drug-Eluting Stent Era

T-H. Yang1, Y-H. Kim1, B-K. Lee1, S-W. Lee2, D-W. Park1, K-H. Park1, B-R. Choi1, C-B.Park1, I-W. Seo1, K-H. Han1, C.W. Lee1, M-K. Hong1, J-J. Kim1, S-W. Park1, S-J. Park1

Asan Medical Center, University of UlsanCollege of Medicine, Seoul, Korea1;Soonchunhyang University Hospital,Bucheon, Korea2

AS-88. Predictors of AngiographicRestenosis After Drug-Eluting StentImplantation in Diabetic Patients withNative Coronary Lesions

T-H. Yang, Y-H. Kim, B-K. Lee, K-M. Park, M-J. Kim, K-H. Park, C-B. Park, I-W. Seo, K-H. Han, C.W. Lee, M-K. Hong, J-J. Kim, S-W. Park, S-J. Park

Asan Medical center, University of UlsanCollege of Medicine, Seoul, Korea

AS-89. Cypher Versus Driver: Six-Month Follow-Up Results of theProspective Randomized Study

J-W. Chung, J-S. Park1, H-J. Kang1, Y-S. Cho2,B-K. Koo1, T-J. Youn2, W-Y. Chung2, I-H. Chae2,D-J. Choi2, H-S. Kim1, D-W. Sohn1, B-H. Oh1, Y-B. Park1, Y-S. Choi1

Cardiovascular Center, Seoul NationalUniversity Hospital1, Bundang SeoulNational University Hospital2, Seoul, Korea

AS-90. First-in-Human Study of EXCEL, a New Sirolimus-Eluting Stent,in Real-World Cases (MEdistra Drug-elutIng STent TRiAl = MEDISTRA)

T. Santoso1, A. Wong2 , T.H. Koh2

Div. of Cardiology, Dept. of InternalMedicine, Univ. of Indonesia MedicalSchool, Jakarta, Indonesia1 , National HeartCenter, Singapore2

AS-91.Drug-Eluting Stent for ChronicTotal Occlusion: Does Length InfluenceOutcome?

T. Santoso

Div. of Cardiology, Univ. of IndonesiaMedical School, Medistra Hospital, Jakarta,Indonesia

AS-92. Prospective Study AssessingHead-to-Head Comparison of Sirolimusand Paclitaxel Drug-Eluting Stents withAngiographic and IntravascularUltrasound Control: Long-TermResults

P. Cervinka1, R. Spacek1 , M. Bystron1 , M. Kvasnak1 , J. Veselka 2

Department of cardiology, Masaryk’shospital Usti nad Labem, Czech Republic1,Department of cardiology, Faculty hospital,Motol, Prague, Czech Republic 2

Abo

ut C

VRF


Invi

ted

Facu

lty

Mee

ting

at a

Gla

nce

Con

tent

sFo

cus

Pro

gram

Abs

trac

tLa

y-O

utO

ffic

ial A

bstr

act G

rade

rs



AS-106. Outcomes of Bare Metal StentsImplanted Simultaneously withSirolimus-Eluting Stents (Cypher) inMultivessel Coronary Artery DiseasePatients: Evaluation of Systemic Effectsof Sirolimus-Eluting Stents

T.S. Kang, Y-W. Yoon, B-K. Hong, H.M. Kwon,S-Y. Cho, H-S. Kim

Division of Cardiology, Yongdong SeveranceHospital, Yonsei University, College ofMedicine, Seoul, Korea

AS-107. Randomized Trial of Sirolimus-Versus Paclitaxel-Eluting Stents forthe Treatment of Acute ST-ElevationMyocardial Infarction: In-Hospital and1-Month Clinical Outcomes

J-H. Lee1, H-S. Kim2 , J-H. Park2 , J-K. Ko2 , S-W. Choi1 , J-O. Jeong1, I-W. Seong1

Chungnam National University Hospital1 ,Chonbuk National University Hospital2 ,Korea

AS-108. Comparison of Sirolimus- andPaclitaxel-Eluting Stents in the RealWorld: Clinical and AngiographicOutcomes from the Korean COronaryMulticenter Angioplasty Team(COMATE) Registry

K.H. Kwon1, S.H. Park1 , S.H. Choi2 , B.K. Lee3 ,B.O. Kim3 , Y.W. Yoon4 , H.M. Kwon4 , S.H. Lee5 , J.H. Yoon5 , S.J. Oh6 , J.Y. Yang6 ,Y.K. Ko7 , Y.S. Jang7

Ehwa Womans University MokdongHospital, Seoul Korea1 , Hallym UniversityKangnam Sacred Heart Hospital, SeoulKorea2 , Inje University Sanggye PaikHospital, Seoul Korea3 , YongdongSeverance Hospital, Seoul Kora4 , WonjuChristian Hospital, Wonju, Korea5 , NHICIlsan Hospital, Ilsan, Korea6 , YonseiUniversity Severance Hospital, Seoul, Korea7

AS-109. Effects of Cilostazol onAngiographic Restenosis AfterCoronary Sirolimus-Eluting Stent (SES)Implantation

S-M. Kim, D-K. Kim, Y-W. Park, D-I. Kim, D-S. Kim

Department of Internal Medicine,Cardiology Division, Inje University Collegeof Medicine, Busan, Korea

AS-110. Can More ThrombogenicRadiocontrast Media Affect the Outcomeof Drug-Eluting Stent Implantation?:Six-Month Follow-Up Results

S-H. Jo, T.J. Youn, B.K. Koo, J. S. Park, H.J. Kang, Y.J. Kim, H.S. Kim, D.W. Sohn, B.H. Oh, M.M. Lee, Y. B. Park, Y.S. Choi

Cardiovascular Center, Seoul NationalUniversity Hospital, CardiovascularLaboratory, Clinical Research Institute, SeoulNational University Hospital, Seoul, Korea

AS-111. MDR-1 Gene Polymorphismsin the Restenosis of Paclitaxel-ElutingStents(Taxus)

C.S. Park, H-J. Youn, W-s. Chung, J-H. Kim, Y-S. Oh, K-W. Moon, J-M. Lee, J-J. Kim, K-B. Seung, J-H. Kim, K-B. Choi, S.J. Hong

Department of Internal Medicine, College ofMedicine, The Catholic University of Korea

AS-112. Immediate and MidtermClinical and Angiographic Outcomes ofMetal Jacket with Silorimus-ElutingStents for the Long-Lesion Coverage

J-S. Park1 , Y-J. Kim1 , D-G. Shin1 , B-S. Shim1

, J-H. Bae1 , C-W. Nam2 , S-H. Hur2 , S-W.Han2

, K-S.Kim2 ,Y-N. Kim2, K-B. Kim2 , D-I. Kim3 , S-M. Kim3 , Y-W. Park3 , D-S. Kim3

Yeungnam University1 , KeimyungUniversity2 , Inje University 3, Korea

AS-113. Sirolimus-Eluting StentImplantation for Unselected In-StentRestenosis

K.H. Cho1, Y.S Jeong1 , S.M. Kim2 , D.I. Kim2 ,D.S. Kim2 , K.B. Kim3 , K.S. Kim3 , S.H. Hur3 ,Y.J. Kim4 , J.S. Park4 , B.S. Shim4

Handong Univ. Sunlin Hospital, Pohang,Korea1 ; Inje Univ. Paik Hospital, Busan,Korea2 ; Keimyung Univ. Dongsan Hospital,Daegu, Korea3 ; Yeungnam Univ. Hospital,Daegu,Korea4

AS-114. Initial Clinical Results ofSirolimus-Eluting Stent Implantationfor Left Main Trunk Disease

S. Nishimura, T. Muramatsu, R. Tsukahara, Y. Ito, K. Hirano, Y. Furuse, T. Tsubota

Division of cardiology,Kawasaki SocialInsurance Hospital, Kanagawa, Japan

AS-115. Short-Term Clinical Outcomeof Intracoronary Sirolimus-ElutingStent Implantation for BifurcationLesions: The j-CYPHER Registry

T. Tamura1, T. Kimura1 , K. Mitsudo2 , on behalf of the j-CYPHER Investigators

Department of Cardiology, Kyoto UniversityHospital 1 , Department of Cardiology,Kurashiki Central Hospital2 , Japan

AS-116. Platelet Activation AfterSirolimus-Eluting Stenting

Y. Jiang1, H. Wang2 , H-M. Liu3 , C. Wu1 , W-M. WANG 1

Cardiac Catheterization Laboratory1, FlowCytometry Laboratory2, ThrombosisLaboratory3, People’s Hospital, BeijingUniversity, China

AS-117. Efficacy and Safety of DES inPrimary Percutaneous CoronaryIntervention: The Korean MulticenterAngioplasty Team (COMATE) Registry

H.S. Jung1, J.H. Yoon1, S.H. Lee1, Y.S. Jang2 ,W.H. Shim2 , H.M. Kwon3 , S.H. Park4, B.O. Kim5, J.Y. Yang6, S.H. Choi7

Wonju Christian Hospital, Wonju, Korea1,Yonsei University Severance Hospital,Seoul, Korea2, Yongdong SeveranceHospital, Seoul, Korea3, Ehwa WomansUniversity Mokdong Hospital, Seoul, Korea4,Inje University Sanggye Paik Hospital,Seoul. Korea5 , NHIC Ilsan Hospital, Ilsan,Korea6 , Hallym University Kangnam SacredHeart Hospital, Seoul, Korea7

AS-118. Persistent Relative Low ShearWithin Sirolimus-Eluting Stents at 30days in the Porcine Coronary Model: APotential Physiological Stimulus forLate Neointimal Formation

A. J. Carter, W. Wei, R. Collingwood, L.Gibson, F. Tio

Borgess Medical Center, MI, USA

AS-119. The Y Bifurcation StentTechnique with the Cypher Stent forBifurcated Coronary Lesion

A. Sueyoshi, T. Tanaka, K. Hamaguchi, T. Amano, S. Matsuoka

Department of Cardiology, Uji TokushukaiMedical Center, Kyoto, Japan

AS-93. The j-Cypher Registry:Surveillance of Sirolimus-Eluting Stentin Routine Clinical Practice in Japan

Y. Nakagawa1, T. Kimura1, K. Mitsudo2 , on behalf of the j-Cypher Investigators

Kyoto Univ. Hospspital, Japan1 , KurashikiCentral Hospital, Japan2

AS-94. One-Year Outcome FollowingSirolimus-Eluting Stent Implantation inCoronary Bifurcation Lesions

L. Ge1, I. Iakovou2 , J. Cosgrave2 , G. Stankovic2,G.M. Sangiorg2 , E. Tsagalou2, F. Airoldi2 , I. Michev 2, A. Chieffo2 , M. Montorfano2, M. Carlino2 , N. Corvaja2 , J. Ge1, A. Colombo2

Department of Cardiology, ZhongshanHospital, Fudan University, Shanghai,China1, EMO Centro Cuore Columbus andSan Raffaele Hospital, Milan, Italy2

AS-95. Comparison of Immediate andLong-Term Outcomes of DirectStenting Using Sirolimus-Eluting Stentwith Predilation Stenting

L. Ge1, I. Iakovou2 , J. Cosgrave2 , G.M. Sangiorg2 , F. Airoldi2 , G. Melzi2 , M. Montorfano2, I. Michev2 , A. Chieffo2 , M. Carlino2 , N. Corvaja2 , J. Ge1, A. Colombo2

Department of Cardiology, ZhongshanHospital, Fudan University, Shanghai,China1, EMO Centro Cuore Columbus andSan Raffaele Hospital, Milan, Italy2

AS-96. Stenting of Left Main CoronaryArtery Stenosis with Drug-ElutingStent: Korean Multicenter AngioplastyTeam Registry

S.H. Lee1, J-H. Jung1, S.H. Choi1, Y.S. Jang2,H.M. Kwon3, J.H. Yoon4, S.H. Park 5, B.O. kim 6,J.Y. Yang 7

Hallym University Kangnam Sacred HeartHospital,Seoul, Korea1, Yonsei UniversitySeverance Hospital,Seoul, Korea2,Yongdong Severance Hospital,Seoul,Korea3, Wonju Christian Hospital, Wonju,Korea4, Ehwa Womans University MokdongHospital, Seoul, Korea5, Inje UniversitySanggye Paik Hospital,Seoul, Korea 6, NHICIlsan Hospital, Goyang, Korea7

AS-97. Predictors of In-StentRestenosis in Patients with Drug-Eluting Stent Implantation

C-W. Nam, S-H. Hur, K-B. Kim, Y-S. Lee, S-H. Lee,S-W. Han, K-S. Kim, Y-N. Kim, Y.K. Cho

Cardiovascular Medicine, KeimyungUniversity College of Medicine, Daegu, Korea

AS-98. Clinical Effects of Drug-ElutingStents in Long Coronary Stenotic Lesions:Catholic Medical Center Registry

D.I. Shin, K.B. Seung, D.B. Kim, S.H. Her, P.J. Kim,K.Y. Chang, S.H. Bak, S.J. Hong, K.B. Choi

Division of Cardiology, College of MedicineThe Catholic University of Korea, Seoul, Korea

AS-99. Predictors of AngiographicRestenosis After Drug-Eluting StentImplantation for Native CoronaryLesions in Real-World Practice

M-J.Kim, Y-H.Kim, T-H.Yang, B-K.Lee, D-W.Park, B-R.Choi, C.W.Lee, M-K.Hong, J-J.Kim, S-W.Park, S-J.Park


AS-100. Utilization Pattern and Long-Term Prognosis of Drug-Eluting Stent Compared with BareMetal Stent in the Real World

D-B. Kim, K-B. Seung, S-H. Hur, D-I. Shin, P-J. Kim, S.H. Baek, C-S. Park, W-S. Chung,J-M. Cho, D-S. Jeon, J-H. Kim, S-J. Hong, K-B. Choi

Division of Cardiology, Department ofInternal Medicine, College of Medicine, TheCatholic University of Korea, Seoul, Korea

AS-101. Drug-Eluting Stent for LeftMain Bifurcation Stenosis: Medium-Term Follow-Up

T. Santoso

Div. of Cardiology, Dept. of InternalMedicine, Univ. of Indonesia Medical School,Medistra Hospital, Jakarta, Indonesia

AS-102. Outcomes of Sirolimus- and Paclitaxel-ElutingStents in Unselected Patients: SNUH-DES Registry Experience

J-Y. Han, H-J. Cho, J-S. Park, J-W. Chung, H-J. Kang, T-J. Youn, B-K. Koo, I-H. Chae, H-S. Kim, B-H. Oh, Y-B. Park

Department of Internal Medicine, SeoulNational University College of Medicine,Seoul, Korea

AS-103. Procedural Success and 30-Day Outcomes Between Cypherand Taxus Stent Implantation for theTreatment of Bifurcation Lesions: A Single-Center Experience

C.H. LEE, H.C. Tan, H.B. Wong, J.J. Zhang, C.Y. Soon, S.G. Teo, A. Low, A. Sutandar, Y.T. Lim

National University Hospital, Singapore

AS-104. Sirolimus-Eluting Stent(Cypher): The Korean MulticenterAngioplasty Team (COMATE) Registry

Y-G. Ko1, Y-S. Jang1, W.H. Shim1, H.M. Kwon2,J.H. Yoon3, S.H. Park4, B.O. Kim5 , J.Y. Yang6,S.H. Choi7

Yonsei University Severance Hospital1,Yongdong Severance Hospital2, WonjuChristian Hospital3, Ehwa WomansUniversity Mokdong Hospital4, InjeUniversity Sanggye Paik Hospital5, NHICIlsan Hospital6, Hallym University KangnamSacred Heart Hospital7, Korea

AS-105. Outcome of Comparison ofSirolimus- (Cypher) Versus Paclitaxel-Eluting Stents (Taxus) in Patients withSmall-Vessel Lesions: The Korean Multicenter AngioplastyTeam (COMATE) Registry

H-S. Seo1, Y-W. Yoon1, H.M. Kwon1, Y.S. Jang2 ,J.H. Yoon3 , S.H. Park4, B-K. Hong1 , B.O. Kim5 ,S.H. Choi6 , J.Y. Yang7

Yonsei University Yongdong SeveranceHospital, Seoul, Korea1, SeveranceHospital, Seoul, Korea2, Wonju ChristianHospital, Wonju, Korea3, Ehwa WomansUniversity Mokdong Hospital, Seoul, Korea4,Inje University Sanggye Paik Hospital,Seoul, Korea5, Hallym University KangnamSacred Heart Hospital, Seoul, Korea6, NHICIlsan Hospital, Seoul, Korea7

Abo

ut C

VRF


Invi

ted

Facu

lty

Mee

ting

at a

Gla

nce

Con

tent

sFo

cus

Pro

gram

Abs

trac

tLa

y-O

utO

ffic

ial A

bstr

act G

rade

rs



GENETIC ORMOLECULARCARDIOLOGYFriday, April 29, 2005, 2:00~4:00 PM


AS-132. Mast Cells Accumulation AfterCoronary Microembolization Contributeto Angiogenesis and PreserveMicrovascular Function

Q.Y. Zhang1 2, H.F. Tse2 , J.Z. Chen1, J.H. Zhu1, Q.G. Zhang1 , J.B. Ge3

The first hospital of Zhejiang University,China1, Queen Mary hospital, HongKongUniversity, China2 , Zhong Shan Hospital,Fudan University, China 3

AS-133. Effects of RemotePreconditioning Induced by SkeletalMuscle Ischemia on MyocardialNecrosis and Apoptosis: Different Rolesof Bradykinin and Opioid Receptors

W. Cui, R.Q. Xie, Y. M. Hao, G.Y. Du, T. Zhang, J. Du, F. Liu, B.H. Li, J.F. Wu

The Second Hospital of Hebei MedicalUniversity, Shijiazhuang, China

AS-134. Effect of IntracoronaryTransplantation of AutologousPeripheral Blood Stem Cell in Patientswith Acute Myocardial Infarction

J-H. Choi, I. Rhee, H-C. Gwon, S-C. Lee, J.D. Sung, S.W. Park, J.S. Kim, E-S. Jeon, D.K. Kim, S.H. Lee, K.P. Hong, J.E. Park, J.D. Seo

Samsung Medical Center, SungkyunkwanUniversity School of Medicine, Seoul, Korea

AS-135. N-Terminal Pro-B-TypeNatriuretic Peptide as a PrognosticMarker in Acute Coronary Syndrome

I. Rhee, E-S. Jeon, K.K. Baek, J.H. Choi, J.D.Sung, S-C. Lee, S.W. Park, H-C. Gwon, J.S.Kim, D-K. Kim, S.H. Lee, K.P. Hong, J.E. Park,J.D. Seo

Cardiac and Vascular Center,Sungkyunkwan University School ofMedicine, Samsung Medical Center, Seoul,Korea

AS-136. Correlations of SerumAdiponectin Levels with the Severity ofCoronary Artery Disease

H.S. Seo, Y-G. Ko, Y-S. Jang, N.S. Chung, W.H. Shim, S.Y Cho

Division of Cardiology, CardiovascularResearch Institute & CardiovascularCenter, Yonsei University, Seoul, Korea

AS-137. Effects of Mesenchymal StemCells Transduced with Akt on PorcineMyocardial Infarction

Y.K. Ahn1, S.Y. Lim1 , M.H. Jeong1 , Y-S. Kim1 ,K.I. Nam1 , M.C. Lee1 , H.C. Song1 , Y.J. Hur1 ,E.H. Bae1 , Y.J. Hong1 , H.W. Park1 , J.H. Kim1 ,W. Kim1 , J.G. Cho1 , J.C. Park1 , J.C. Kang1 , A. Rosenzweig2 , T. Matsui2

Chonnam National University MedicalSchool, Gwangju, South, Korea 1 ,Massachusetts General Hospital, Boston, USA2

AS-138. Bioluminescence Imaging ofCord-Blood-Derived MesenchymalStem Cell Transplantation intoMyocardium

J-J. Min1, Y.K. Ahn2, S.M. Moon1, S.Y. Lim2, K.H. Yun2, Y-J. Heo1, H-C. Song1, M.H. Jeong2,H-S. Bom1

Department of Nuclear Medicine, ChonnamNational University Medical School1 ,Department of Internal Medicine, ChonnamNational University Medical School2,Gwangju, Korea

AS-139. Activated Fork HeadTranscription Factor Inhibits NeointimalHyperplasia After Angioplasty ThroughInduction of p27

K-W. Park2, D-H. Kim2, H-J. You1, S-I. Jeon1, S-W. Youn1, H-M. Yang2, H-S. Kim2, Y-B. Park2

Cardiovascular Laboratory, ClinicalResearch Institute, Seoul NationalUniversity Hospital1, Department of InternalMedicine, Seoul National University Collegeof Medicine, Seoul, Korea2

MISCELLANEOUSSaturday, April 30, 2005, 9:00~11:00 AM


AS-140. Percutaneous Treatment ofAortic Aneurysms: Long-Term Follow-Up

M. Skowasch1, H. Lissmann-Jensen1, K. Lang 1,A. Roemer1 ,I. Hoffmann1 , T. Middeldorf 1, U. Finke2,W. Seemann3 , M. Tischendorf 3 , H. Sievert1

CardioVascular Center Frankfurt, SanktKatharinen and Medizinische Klinik I, SanktKatharinen Krankenhaus, Frankfurt,Hessen1 , Chirurgische Klinik, SanktKatharinen Krankenhaus, Frankfurt,Hessen2 , Abteilung Radiologie/MRT, SanktKatharinen Krankenhaus, Frankfurt,Hessen, Germany3

AS-141. Coronary Flow Reserve in thePatients with Early Abnormal GlucoseMetabolism

Q. Zhang, R. Zhang, J. Zhang, J. Hu, Z. Yang,W. Sheng

Shanghai Ruijin Hospital affiliated toShanghai Second Medical University,Shanghai, China

AS-142. Recent 8-Year Trends of theIsolated Significant Left Main CoronaryArtery in Samsung Medical Center:Clinical and Angiographic Findings, andTreatment Modalities of Long-TermFollowed-Up of 50 Patients

Il Rhee, J.E. Park, S.H. Lee, K.P. Hong, S.D. Seo


AS-143. Prognosis of No-ReflowPhenomenon in Patients AfterPercutaneous Coronary Intervention

H.L. Cong, J.B. Du, M. Zhang, W. Wang, Y. Xu,X. T. Chen, G.P. Li, T.G. Huang

NO2 Hospital of Tianjin Medical University,Hexi Dist, Tianjin, China

AS-120. Comparing the Safety andEfficacy of Sirolimus-Eluting Stentsand Common Bare Stents

I. Nazeri, A. Nazeri, S. Shokoufi-Moghiman, K. Hashemy

Tehran Medical University, Nazeri HeartInstitute, Tehran, Iran

AS-121. Drug-Eluting Stent Implantationin Real-World Practice: A 6-MonthFollow-Up Report from Validating theEfficacies of DES implantation BeyondsiRIus and TAxus at Seoul NationalUniversity Hospital (VERITAS) Registry

I.H. Chae2 , J.S. Park1 ,H.J. Kang1 , Y.S. Cho2 ,T.J. Youn2 , W.Y. Chung2 , B.K. Koo1, D.J. Choi2

, H.S. Kim1 , D.W. Sohn1, B.H. Oh1, M.M. Lee1,Y.B. Park1 , Y.S. Choi1


AS-122. Drug-Eluting Stent Restenosisin Real-World Clinical Practice: 6 Month Angiographic Follow-UpResults

S-W. Rha, B.W. Cheon, S.K. Moon, H.H. Kim,J.W. Kim, S.J. Hong, C.G. Park, H.S. Seo, D.J. Oh

Cardiovascular Center, Korea UniversityGuro Hospital, Seoul, Korea

AS-123. Short-Term Clinical Resultswith Drug-Eluting Stents: Cypher Versus Taxus

V. Sharma, A. Tripathi

National Heart Institute, All India HeartFoundation, New Delhi, India

INTRAVASCULARULTRASOUNDFriday, April 29, 2005, 2:00~4:00 PM


AS-124. Lesion Morphologies of"Transient No-Reflow" DuringPercutaneous Coronary Intervention inAcute Coronary Syndromes: An Intravascular Ultrasound Study

H. Shinji, R. Iijima, H. Itaya, K. Makino, H. Hara, T. Tsunoda, M. Nakamura

Toho university Ohashi HospitalDepartment of Cardiovascular Medicine,Tokyo, Japan

AS-125. Pre-Interventional PeakMonocyte Count and In-Stent IntimalHyperplasia After Coronary StentImplantation in Human Coronary Arteries

Y.J. Hong, M.H. Jeong, W. Kim, S.Y. Lim, S.H. Lee, S.N. Hong, K.H. Yun, K.H. Kim, D.G. Kang, Y.S. Lee, J.H. Kim, Y.K. Ahn, J.G. Cho, J.C. Park, J.C. Kang


AS-126. Effects of Statins on Clinical Restenosis and NeointimalHyperplasia After Successful CoronaryArtery Stenting: An Intravascular Ultrasound Study

Y.J. Hong, W. Kim, S.Y. Lim, S.H. Lee, S.N. Hong, K.H. Yun, K.H. Kim, D.G. Kang, Y.S. Lee, J.H. Kim, Y.K. Ahn, J.G. Cho, J.C. Park, J.C. Kang


AS-127. Impact of Optimal StentExpansion on 6-Month AngiographicRestenosis and Clinical Outcome in theEra of Drug-Eluting Stent: An Intravascular Ultrasound Study

C-W. Nam, K-B. Kim , S-H. Hur , Y-S. Lee, S-W. Han, K-S. Kim, S-H. Lee, Y-N. Kim, J-H. Jeon, H-C. Choi, S-H. Hwang

Cardiovascular Medicine, KeimyungUniversity College of Medicine, Deagu,Korea

AS-128. Influence of IntravascularUltrasound-Guided Stenting DuringPrimary Coronary Stenting in Patientwith Acute Myocardial Infarction

M-J. Kim, S-H. Hur, K-B. Kim, J-H. Jeon, S-H. Hwang, H-C. Choi, Y-S. Lee, C-W. Nam,S-H. Lee, S-W. Han, K-S. Kim, Y-N. Kim

Cardiovascular Medicine, KeimyungUniversity College of Medicine, Daegu,Korea

AS-129. Relationship Between VascularMorphology and Long-Term ClinicalEvents in Variant Angina Documentedby Ergonovine Provocation Test

S-Y. Choi, S-J. Tahk, M-H. Yoon, S-G. Ahn, B-J. Choi, Z-G. Zheng, J-H. Choi, S-Y. Yoo,G-S. Hwang, J-H. Shin

Ajou University School of Medicine, Suwon,Korea

AS-130. Value and Limitation ofIntravascular Ultrasound and CoronaryAngiography for the Prediction of Slowor No Flow During and After CoronaryIntervention

T. Watanabe, H. Mastuo, S. Watanabe, S. Warita, T. Kojima, T. Shiraki, M. Iwama, T. Hirose, K. Ono, M. Kouda, H. Takahashi, T. Segawa, Y. Mastuno

Department of Cardiology, Gifu PrefecturalHospital, Gfu, Japan

AS-131. lntravascular UltrasoundStudy of “Normal” Coronary ArteryReference Segments in CoronaryAngioplasty

G. Liu, L. Li, J. Zhao

Department of Research and development,Tianjin JINLONGKANG Institute of MedicalScience, Tianjin, China

Abo

ut C

VRF


Invi

ted

Facu

lty

Mee

ting

at a

Gla

nce

Con

tent

sFo

cus

Pro

gram

Abs

trac

tLa

y-O

utO

ffic

ial A

bstr

act G

rade

rs



AS-159. Decreased Compression Timeand Improved Hemostasis Using aHemostatic Pad with MechanicalCompression After TransradialCoronary Procedures

J-Y. Kim, J.h. Yoon, I-H. Jung, H-S. Wang, H-S. Jung, B-S. Yoo, S-H. Lee, K-H. Choe

Department of Cardiology, Wonju College ofMedicine, Yonsei University, Wonju, Korea

AS-160. Feasibility and Safety ofTransradial Approach in Patients withAortocoronary Bypass Grafts

M. Sanmartin, D. Cuevas, J. Moxica, M.Valdes, JA. Baz, R. Mantilla, A. Ortiz, A.Iniguez

Hospital Meixoeiro. Unidad de CardiologyIntervencionista, Vigo. Spain

AS-161. Optimal Dose of Adenosine forCoronary Flow Reserve and FractionalFlow Reserve Measurements

J-W. Suh, B-K. Koo, H-S. Kim, D-W. Sohn, B-H. Oh, M-M. Lee, Y-B. Park, Y-S. Choi

Cardiovascular Center, Seoul NationalUniversity Hospital, Seoul, Korea

AS-162. Role of Aortic Stiffness onCoronary Artery Atherosclerosis

J.S. Park1, J.J. Seo1, H.J. Kang1 , T.J. Youn2 ,B.K. Koo1, H.S. Kim1 , D.W. Sohn1, M.M. Lee1,Y.B. Park1, Y.S. Choi1, B.H. Oh1


AS-163. Decrease in PlasmaAdiponectin Concentrations in Patientswith Variant Angina and AcuteCoronary Syndrome

S.J. Hong, C.G. Park, H.S. Seo, J.W. Kim, S.W. Rha, D.J. Oh

Department of Cardiology, CardiovascularCenter, Korea University Hospital, Seoul,Korea

AS-164. Subclinical ThyroidDysfunction in Patients UndergoingPercutaneous Coronary Intervention with Drug-Eluting Stents

S-W. Rha, SK Moon, BW. Cheon, HH. Kim, JW. Kim, SJ. Hong, CG. Park, HS. Seo, DJ. Oh


AS-165. Restenosis After SuboptimalBifurcation Stenting Associated withClosed Cell Design of the S670 Stent

C. Obara, M. Ochiai, K. Ashida, H. Araki, H.Okabayashi, N. Ogata

The Division of Cardiology andCardiovascular Surgery, Showa NniversityNorthern Yokohama Hospital, Kanagawa,Japan

AS-166. Ischemia-Modified Albumin isNot Useful in the Setting of Exercise-Induced Myocardial Ischemia

J.H. Kim 1, H.K.Lee1 , Y.H Park1 , W.H.Bae1 ,K.J.Chun1 , T.J.Hong1 , Y.W. Shin1 , H.H. Kim2

Deparment of Internal Medicine, PusanNational University Hospital1 , Departmentof Clinical Pathology, Pusan NationalUniversity Hospital, Busan, Korea2

NEWINTERVENTIONALDEVICESaturday, April 30, 2005, 9:00~11:00 AM


AS-167. Evaluation of PlateletAggregation and the CoagulationCascade of Secondary HemostasisAfter Implantation of New Arterial BY-S-Stent in Animals

V.A. Herasevich1, V.T. Minchenya2, A.G.Mrochek1

The Byelorussian Medical Academy of PostGraduate Education, Minsk, Belarus1 ; The Byelorussian National TechnicalUniversity, Minsk, Belarus2

AS-168. Initial Experiences with theProxis System: A Proximal OcclusionDevice for Embolic Protection DuringPercutaneous Coronary Intervention

M. Skowasch1, J. Schofer2 , K. Diedrich3 , G. Schuler3, G. Suetsch4, H. Sievert1

CardioVascular Center Frankfurt, Hessen,Germany1, Andreas Gruntzig Haus, Hamburg,Hamburg, Germany2 , Heart Center Leipzig,Leipzig, Sachsen, Germany3 , UniversityHospital Zurich, Kanton Zurich, Switzerland4

AS-169. A Comparative Study onManipulation and Imaging of 4Fr Versus 6Fr Catheters byTransradial Coronary Angiography

X. Fu, J. Liu, W. Wu, X. Gu, S. Li


AS-170. “See and Aspirate”: A Novel Coronary Angioscope for theTreatment of Acute Coronary Syndrome

A. Itoh, T. Naruko, M. Otsuka, Y. Sakanoue, R. Komatsu, Y. Abe, T. Imai, K. Shimamura, T. Adachi, K. Kono, N. Shirai, K. Fujimoto, K. Haze

Osaka City General Hospital, Osaka, Japan

AS-144. Peripheral Eosinophil Countand History of Allergy in Patients withCoronary Artery Disease

A. E. Nadimi, J. Ahmadi, M. Mehrabian

Rafsanjan Medical University, Rafsanjan,Kerman, Iran

AS-145. Effects of No-ReflowPhenomenon Identified by MyocardialBlush Grades on Systolic Function andSynchrony in Patients with AcuteMyocardial Infarction AfterPercutaneous Coronary Intervention

X. Fu, J. Liu, W. Wu, X. Gu


AS-146. Atlantis SR Plus/Pro"Intravascular Ultrasound Probe Can BeUsed Safety with 5Fr Guide Catheter

K. Yoshida1 , C. Kawashima2

Cardiovascular Division, Aino MemorialHospital, Japan1 , Cardiovascular Division,National Minami-Kyushu Hospital, Japan2

AS-147. The Sheathless TransfemoralApproach with a 4Fr. AngiographicCatheter for Diagnostic CardiacCatheterization

K. Yoshida1, A. Tsuneto2 , C. Kawashima3

Cardiovascular Division, Aino MemorialHospital, Japan1, Cardiovascular Division,National Nagasaki Medical Center ofNeurology, Japan2 , Cardiovascular division,National Minami-Kyushu Hospital, Japan3

AS-148. Increased Arterial Stiffnessin Patients with Cardiac Syndrome X

Y-S. Lee, K-S. Kim, C-W. Nam, S-H. Lee, S-W.Han, S-H. Hur, Y-N. Kim, K-B. Kim

Division of Cardiology, Internal Medicine,Dongsan Medical Center, KeimyungUniversity, Daegu, Korea

AS-149. Can Pulse Wave Velocity PredictSeverity of Coronary Artery Disease?

Y-S. Lee, K-S. Kim, C-W. Nam, S-H. Lee, S-W.Han

Division of Cardiology, Dongsan MedicalCenter, Keimyung University, Daegu, Korea

AS-150. Transradial Intervention forChronic Total Occlusion: 5Fr Versus 6Fr Approach

H-C. Gwon, C.W. You, J.H. Choi, S.H. Lee, K.P.Hong, J. E. Park

Cardiac and Vascular Center, SamsungMedical Center, Sungkyunkwan UniversitySchool of Medicine, Seoul, Korea

AS-151. Incidence of GastroesophagealDisease in Patients with Normal orMinimal Coronary Artery Disease

C-W. Nam, K-S. Kim, Y-S. Lee, S-H. Lee , S-W. Han, S-H. Hur, K-B. Kim,Y-N. Kim, Y-K. Cho

Cardiovascular Medicine, KeimyungUniversity College of Medicine, Daegu, Korea

AS-152. Relation between AcuteChange of Cell Adhesion Molecules andLate Lumen Loss

T. Tsuchiya, M. Namura, M. Ikeda, H. Terai

Kanazawa Cardiovascular Hospital,Kanazawa, Japan

AS-153. Usefulness of Brain NatriureticPeptide in Early Diagnosis of RightVentricular Infarction

H.G. Lee, K.J. Chun, J.H. Oh, D.W. Lee, W.H. Bae, W.S. Ko, Y.H. Park, J.H. Kim, T.J. Hong, Y.W. Shin

Cardiology Division, Department of InternalMedicine, Pusan National UniversityHospital, Pusan, Korea

AS-154. Clinical Significance ofSuccessful Recanalization in Patientswith Chronic Total Occlusion

J.H. Heo, H.S. Kim, S.C. Shin, D.H. Yang, H.S. Park, Y.K. Cho, S.C. Chae, J.U. Jun, W.H. Park

Department of Cardiology, KyungPooknational university hospital, Daegu, Korea

AS-155. N-Terminal Pro-B-TypeNatriuretic Peptide in the Prediction ofCoronary Artery Disease in UnstableAngina Patients with Normal Troponin Iand Electocardiography

S.N. Hong, Y.K. Ahn, N.S. Yoon, S.Y. Lim, K.H. Yun, D.K. Kang, S.H. Lee, Y.S. Lee, K.H. Kim, Y.J. Hong, H.W. Park, J.H. Kim, W. Kim, M.H. Jeong, J.G. Cho, J.C. Park, J.C.Kang

The Heart Center of Chonnam NationalUniversity Hospital, Gwangju, Korea

AS-156. Prognosis and Remission ofVasospastic Angina Among KoreanPatients in a Period of Several Years

P-J. Kim, K-B.Seung, D-B. Kim, S-H. Her, D-I.Shin, K.Y. Chang, S.H. Baek, S-J. Hong, K-B.Choi

Division of Cardiology, College of Medicine,The Catholic University of Korea, Seoul,Korea

AS-157. Effect of N-Acetylcysteine inthe Prevention of Contrast-InducedNephropathy After CoronaryAngiography

J. Namgung1 , J.H. Doh, S.Y. Lee, W.R. Lee

Inje University Ilsan Paik Hospital,Gyeonggi-do, Korea

AS-158. Can Ischemia-ModifiedAlbumin Predict Coronary ArteryDisease in Patents with Acute ChestPain with Negative Creatine Kinase-MBand Troponin I?

J-Y. Kim1, J.H. Yoon1 , I-H. Jung1 , H-S. Wang1,H-S. Jung1 , B-S. Yoo1 , S-H. Lee1, S-O. Hwang2,K-H. Choe1

Department of Cardiology1, EmergencyMedicine2, Wonju College of Medicine,Yonsei University, Wonju, Korea

Abo

ut C

VRF


Invi

ted

Facu

lty

Mee

ting

at a

Gla

nce

Con

tent

sFo

cus

Pro

gram

Abs

trac

tLa

y-O

utO

ffic

ial A

bstr

act G

rade

rs



PERIPHERALINTERVENTIONSaturday, April 30, 2005, 9:00~11:00 AM


AS-184. Treatment of Chronic AorticDissection with the Inoue Stent-Grafts:Short- to Medium-Term Results in 16Patients

N. Saito1, T. Kimura1, K. Odashiro2, M. Toma1,M. Nobuyoshi2, K. Ueno3, T. Kita1, K. Inoue4

Department of Cardiovascular Medicine,Graduate School of Medicine, KyotoUniversity, Japan1, Department ofCardiology, Kokura Memorial Hospital2,Department of Radiology, Takeda Hospital,Japan3, Institute of PTMC, Japan4

AS-185. Prevalence of Renal ArteryStenosis in Patients UndergoingCoronary Angiography

Q. Zhang, R. Zhang, J. Zhang, J. Hu, Z. Yang,W. Sheng

Shanghai Ruijin Hospital, Shanghai, China

AS-186. Comparison of Subintimal andIntraluminal Angioplasty in LongSuperficial Femoral Artery OcclusiveLesions: Single-Center Registry

Y-G. Ko, D-H. Choi, Y-S. Jang, W-H. Shim

Cardiology Division, Yonsei CardiovascularCenter & Research Institute, YonseiUniversity College of Medicine, Seoul,Korea

AS-187. Acute and Long-Term Outcomeof LUMINEXX Stent Implantation forPeripheral Artery Disease (PAD)

Y. Miyashita, S. Saito, S. Tanaka, S.Takahashi, T. Shiono, H. Domae

Shonan Kamakura General Hospital,Kamakura, Kanagawa, Japan

PHARMACOLOGICALTREATMENTSaturday, April 30, 2005, 9:00~11:00 AM


AS-188. Preprocedural Statin TherapyReduces the Risk and Extent of CardiacBiomarker Release FollowingPercutaneous Coronary Intervention

J. Veselka1,S. Prochazkova1, R. Duchonova1, I. Homolova1, D. Tesar2, P. Cervinka3, K. A. Bybee4

Dpt. of Cardiology, Hospital Motol, Prague,CZ1, Dpt. of Imaging Methods, HospitalMotol, Prague CZ2, Dpt. of Cardiology,Hospital Usti n.L., CZ3, Dpt. ofCardiovascular Medicine, Mayo Clinic andFoundation, Rochester, MN4

AS-189. Antiplatelet Activity Was NotReduced by Atorvastatin Combinedwith Long-Term Clopidogrel Comparedwith Fluvastatin

J.K. Kim1, J.H. Lee2 ,J.H. Kim1 ,R.K. Choi3 ,H.K. Hwang3

Department of Cardiovascular Medicine,Sun General Hospital, Daejeon, Korea1,Department of Cardiovascular Medicine,Chungnam National University Hospital,Daejeon, Korea2 ,Department ofCardiovascular Medicine, Sejong GeneralHospital, Bucheon, Korea3

AS-190. Effectiveness of TripleAntiplatelet Therapy with Aspirin,Clopidogrel, and Cilostazol on PlateletAggregation and GlycoproteinExpression

B-K. Lee, S-W. Park, S-W. Lee, K-M. Park, D-W. park, M-J. Kim, Y-H. Kim, C.W. Lee, M-K.Hong, J-J. Kim, S-J. Park


AS-191. Prospective, RandomizedClinical Trial with Low MolecularWeight Heparin or UnfractionatedHeparin as PeriproceduralAnticoagulant During ElectivePercutaneous Coronary Intervention

S.H. Her, K.B. Seung, D.B. Kim, D.I. Shin, P.J.Kim, K.Y. Chang, S.H. Bak, S.J. Hong, K.B.Choi

Division of Cardiology, College of MedicineThe Catholic University of Korea, Seoul,Korea

AS-192. Effect of Carvedilol on theCoronary Vascular EndothelialFunction After PercutaneousTransluminal Coronary Angioplasty

J. Yao, W. Zhao, L. Li

Tianjin PULUOBI Bioengineering TechniqueCo Ltd, Tianjin, China

AS-193. Intrasheath Fraxiparin inPercutaneous Coronary Intervention

Z. Min, M.Zhao, S.Q.Jia, X.Chen

Heart&Blood Vessel Center affiliated ofCapital University of Medical Sciences,Beijing, China

AS-194. Pravastatin Early Use in AcuteCoronary Evaluation (PEACE) Trial

Z. Min1, M.Zhao1 ,S.Q.Jia1

Heart&Blood Vessel Center, BeijingFriendship Hospital affiliated of CapitalUniversity of Medical Sciences1

AS-195. Safety and Efficacy of High-Loading-Dose ClopidogrelTherapy in Patients UndergoingPercutaneous Coronary Intervention

S-W. Rha, B.W. Cheon, H.H. Kim, S.K. Moon, J.W. Kim, S.J. Hong, C.G. Park, H.S. Seo, D.J. Oh


AS-171. The 5 in 6 Study

S. Takahashi, S. Saito

Shonan Kamakura General Hospital,Kanagawa, Japan

AS-172. Initial Clinical Results of Tornus:The New Penetrating Microcatheter forChronic Total Occlusion

S. Nishimura, T. Muramatsu, R. Tsukahara, Y. Ito, K. Hirano, Y. Furuse, T. Tsubota

Division of cardiology, Kawasaki SocialInsurance Hospital, Kanagawa, Japan

AS-173. Approach to Post-MyocardialInfarction Ventricular Septal Defect:Conservative Percutaneous DeviceClosure or Surgical Repair

R. Kapoor, A. Mathur, P. Gupta, S. Radhakrishnan, S. Srivastava, A. Seth, N. Chandra, R. R. Kasliwal, N. Trehan

Escorts Heart Institute And ResearchCentre, Okhla Road, New Delhi, India

AS-174. PercutaneousCardiopulmonary Support in CardiacArrest or Cardiogenic Shock: Extracorporeal Membrane OxygenationExperiences in Samsung Medical Center

I. Rhee, H-C. Gwon, I-K. Sung, JH. Choi, SH.Lee, KP. Hong, JE. Park, JD. Seo


NONCORONARYCARDIACINTERVENTIONSaturday, April 30, 2005, 9:00~11:00 AM


AS-175. Comparison of Clinical Efficacyof Percutaneous Mitral BalloonValvuloplasty Versus Open HeartSurgery in Patients with MitralStenosis and Resting PulmonaryHypertension

B-K. Lee, J-K. Song, S-J. Kang, K-M. Park, D-H. Kang, J-M. Song, K-H. Han, Y-H. Kim, M-K. Hong, C. W. Lee, S-W. Park, S-J. Park


AS-176. Clinical Study on a Chinese-Made Amplatzer Occluder Device toTreat Perimembrane VentricularSeptal Defect

Z.G. Ji1, G. Liu , Z Wang, K.S. Liu

Cardiovascular Department of The FirstHospital of Hebei Medical University,Shijiazhuang, Hebei Province, PR China 1

AS-177. Alcohol Septal Ablation forObstructive HypertrophicCardiomyopathy: Slower HemodynamicImprovement and Septum ThicknessReduction in Younger Patiens

J. Veselka1, R. Duchonova1, S. Prochazkova1, I. Homolova1 , J. Palenickova1, P. Cervinka2, D. Tesar3

Dpt. of Cardiology, Hospital Motol, Prague,CZ1, Dpt. of Cardiology, Hospital Usti n.L.,CZ2, Dpt. of Imaging Methods, HospitalMotol, Prague, CZ3

AS-178. New Velocimed Premere PFOClosure Device: First in Human Results

M. Skowasch1, F. Buescheck1, M. Taaffe1 , Y. Bayard1 , R. Hein1 , H. Lissmann-Jensen1 , A. Roemer1 , K. Lang1 , I. Hoffmann1 , T. Middeldorf1 , E. Heilmann2 , F. Kleber2 , H.Sievert1

CardioVascular Center Frankfurt, SanktKatharinen, Frankfurt, Hessen, Germany 1 ,Humbolt University Hospital Berlin, Berlin,Germany2

AS-179. Long-Term Follow-Up ofEndovascular Treatment for AorticDissection

Zh.Q. Pang, J.Sh. Gao, X.M. Zheng

Tangshan Kailuan Hospital, HebeiTangshan, China

AS-180. Alcohol Septal Ablation Therapyin Patients with HypertrophicObstructive Cardiomyopathy: Asan Medical Center Experience of theFirst Series of 37 Patients

J.M. Ahn, C.W. Lee, Y-H. Kim, M-K. Hong, K-H. Han, J-K. Song, J-J. Kim, S-W. Park, S-J. Park

University of Ulsan, Asan Medical Center,Seoul, Korea

AS-181. Long-Term Clinical Outcome ofModerate to Severe MitralRegurgitation After PercutaneousMitral Valvuloplasty

I. Rhee, S-C. Lee, S.H. Kim, S.W. Park, S.H. Lee, K.P. Hong, J.E. Park, J.D. Seo


AS-182. Alcohol Septal Ablation-Taiwan Experience

P-H. Lo, J-Y. Fung, J-S. Hung

China Medical University Hospital,Taichung, Taiwan

AS-183. Frequency, Risk Factors, andPrognosis of Stent Thrombosis AfterPrimary Percutaneous CoronaryIntervention

D. Qu, W. Liu, Y. Zhou

Tianjin Xinhua Hospital, Tianjin, China

Abo

ut C

VRF



Invi

ted

Facu

lty

Mee

ting

at a

Gla

nce

Con

tent

sFo

cus

Pro

gram

Abs

trac

tLa

y-O

utO

ffic

ial A

bstr

act G

rade

rs

38/39_Poster Abstract Presentations/About CVRF

VASCULARBRACHYTHERAPYSaturday, April 30, 2005, 9:00~11:00 AM


AS-196. Late Catch-Up and ClinicalOutcomes Beyond 6 Months After Beta-Radiation Therapy with a Rhenium-188Mercaptoacetyltriglycine (188Re-MAG3) Filled Balloon for theTreatment of Diffuse In-StentRestenosis

S-W. Lee1, S-W. Park2 , D.H. Moon3 , S-J. Oh3 ,N-H. Lee1, Y-H. Cho1, T-H. Yang2 , B-K. Lee2 ,Y-H. Kim2 , C.W. Lee2 , M-K. Hong2 , J-J. Kim2 ,S-J. Park2

Department of Medicine, SoonchunhyangUniversity Bucheon Hospital, Bucheon,Korea1, Department of Medicine, AsanMedical Center, University of Ulsan Collegeof Medicine, Seoul, Korea2, Department ofNuclear MedicineAsan Medical Center,University of Ulsan College of Medicine,Seoul, Korea 3

AS-197. Five-Year Follow-Up AfterTreatment of Diffuse In-StentRestenosis with Rotational AtherectomyFollowed by Beta-Radiation Therapywith a 188Re-MAG3-Filled Balloon

S-W. Lee1, S-W. Park2, M-K. Hong2, Y-H. Kim2,D.H. Moon3, S-J. Oh3, D-W. Park2, K.M. Park2,B-R. Choi2, N-H. Lee1, Y-H. Cho1, C.W. Lee2, J-J. Kim2, S-J. Park2

Department of Medicine,SoonchunhyangUniversity Bucheon hospital, Bucheon,Korea1, Department of Medicine, AsanMedical Center,Seoul, Korea2, Departmentof Nuclear Medicine, Asan MedicalCenter,Seoul, Korea3

VULNERABLEPLAQUESaturday, April 30, 2005, 9:00~11:00 AM


AS-198. Contrast-Enhanced High-Resolution MRI for Characteristics ofCarotid Atheroma Prolonged Treatedwith Lipid-Lowering Therapy

I. Rhee, J.E. Park, Y.H. Choe, S.H. Lee, K.P.Hong, S.D. Seo


AS-199. Temperature Difference ofAtherosclerotic Plaque and NormalVessel Wall Predict Distal EmbolizationAfter Percutaneous Coronary Stenting

S-Y. Choi, S-J. Tahk, B-J. Choi, M-H. Yoon, S-G. Ahn, Z-G. Zheng, S-Y. Yoo, J-H. Choi, G-S.Hwang, J-H. Shin


AS-200. Relationship Between ThermalHeterogeneity of AtheroscleroticPlaques and Plaque Vulnerability UsingRadi Wire: Intravascular UltrasoundStudy

B-J. Choi, S-Y. Choi, S-J. Tahk, M-H. Yoon, T-Y. Choi, S-G. Ahn, S-Y. Yoo, J-H. Choi, G-S.Hwang, J-H. Shin


Angioplasty Summit – TCT Asia Pacific started in 1995 and now it has become one of the major educational programs for the global communication of interventionalcardiology. After the establishment of CVRF, we carried out the 8th and 9th Angioplasty Summit successfully and preparing the 10thmeeting as the most significant one under the name of the Angioplasty Summit 2005-TCT Asia Pacific. (www.summitmd.com)

On & Off line Education>> www.summitMD.comIs an educational program on website opened in 2002. It is a clinical case-oriented educational website continuously providing the mostupdated information.

>> Practical Workshop for young interventional cardiologistsheld twice a year helps the Participants to obtain hand-on-experiences through 2-way communication, and conducts case reviews andfree discussions with specialists under the specific main theme for each workshop.

>> Training ProgramsAre designed to provide participants with concentrated experiences in cardiovascular intervention including exposure to currentpractices in Japan, USA, and Europe.

- Short-term Training Program: 2 participants every semester for 2 months

- Long-term Training Program: 1 participant every year for 1 year

Clinical ResearchGood research is critical to patient care. Our goal is to become an important member of the international research community byconducting and financially supporting multi-national and multi-center, basic and clinical research studies.

We are supplying annual research funding for distinguished projects to support basic & multi institutional clinical trials oncardiovascular diseases and interventional procedures to activate fine studies.

About CVRFCardioVascular Research Foundation AsiaCardioVascular Research Foundation(CVRF) was established as a non-profit organization approved by the Ministry ofHealth and Welfare in Korea to contribute to the improvement in the health of human being. ( www.cvrf.org )

Abo

ut C

VRF


Invi

ted

Facu

lty

Mee

ting

at a

Gla

nce

Con

tent

sFo

cus

Pro

gram

Abs

trac

tLa

y-O

utO

ffic

ial A

bstr

act G

rade

rs

40/41_ Contributor Acknowledgement/Exhibit Booth Lay-Out

Exhibit Booth Lay-Out_The CVRF wishes to express our sincere appreciations to the following companies for the support of theireducational grants and participation in the Angioplasty Summit 2005-TCT Asia Pacific meeting

Exhibit location Exhibit Hall, Level B1, Sheraton Grande Walkerhill

Seoul Hotel

Exhibit HoursThursday, April 28, 2005, 1:00 PM - 6:00 PM

Friday, April 29, 2005, 9:00 AM - 6:00 PM

Saturday, April 30, 2005, 9:00 AM - 4:00 PM

Angioplasty Summit 2005-TCT Asia Pacific

A 1 Guerbet KoreaA 2 Taejoon Pharm.Co., LtdA 3 Abbott Korea Ltd.A 4 ILSUNG PharmaceuticalsA 5 Philips Medical SystemsA 6 Hyundai Pharm A 7 PavmedA 8 Novartis Korea Ltd.A 9 Cardiotec Co., LtdA 10 Camicmed Co. LtdA 11 Schering (Korea) LtdA 12 Kunwha Pharmaceutical Co., LtdA 13 Vasocare Co., LtdA 14 GlaxoSmithKlineA 15 Korea Unipharm co,LtdA 16 BORYUNG PHARM.CO., LTD.A 17 GE HealthcareA 18 Daeil Co., LtdA 19 Jungsung Medical Co.LtdA 20 St.Jude MedicalA 21 SITEC MEDICALA 22 B.Braun Korea

A 23 MedWin Co., Ltd.A 24 Kyung Poong PharmaA 25 Pfizer KoreaA 26 Jin Young CP Co., Ltd/Goodman KoreaA 27 Korea Otsuka Pharm Co.Ltd.A 28 Book Selling A 29 Elsevier (Singapore) Pte LtdA 30 Chung Kun DangA 31 MSD KOREAA 32 Hanmi Parmaceultical Co., LtdA 33 amg KoreaA 34 Medtronic KoreaA 35 Johnson & Johnson Medical Korea Ltd.A 36 Guidant Intercontinental CorporationA 37 Siemens Ltd.A 38 Orbus Neich(Korea) Company Limited.A 39 Terumo Korea CorporationA 40 Boston Scientific KoreaA 41 Bristol-Myers Squibb Company

B 1 Cyber StaionB 2 Exhibitor's Help Desk

Booth No. Company Name Booth No. Company Name

Angioplasty Summit 2005-TCT Asia Pacific wishes to express our sincere gratitude to the following contributors and thededicated individuals for the meeting. Their unrestricted efforts and passions have made this distinctive meeting moreadvanced and fruitful.

Contributor Acknowledgement_

Academic ProgramMyeong-Ki Hong, MD Cheol-Whan Lee, MDYoung-Hak Kim, MD Bong-Ki Lee, MDHyun Sook Kim, MD Jae-Hwan Lee, MDSeung-Whan Lee, MD Duck Woo Park, MDKyung-Min Park, MD Tae Hyun Yang, MD

CardioVascular Research Foundation AsiaKyung-Ae Kim, Meeting Planner, RN, Academic ProgramsChesil Lee, Manager, Academic Programs, ExhibitionSoon-Jung Rho, Manager, Website, Graphic DesignJune Gwon, Manager, Accounting DevelopmentMi-Kyung Jung, Executive Assistant to Seung-Jung Park, MDYoung-Hee Kim, RN, Coordinator, Clinical Research

Clinical Research Center for Ischemic Heart disease, The Korea Ministry of Health and WelfareMinnie Kim, Coordinator, Clinical ResearchSoon-Hee Hwang, Assistant Coordinator, Clinical Research

Asan Medical CenterJae Yun Ko, RT, Project Manager, Video Production ServicesMin Suk Lee, RT, Manager, Network ServicesKang-Soo Jung, RT, Manager, Video Production Services

Cardiac Catheterization Laboratory, Asan Medical CenterSoon Deok Jang, RT Deok Cheol Jeong, RTHea Young Jo, NA Ho Jung Kim, RTHyo jin Kim, RN Ju Hee Kim, RNEun Jeong Lee, RN Jung Sook Oh, RNHyun Kyung Park, RN Ji Yeon Park, NAJin Seok Roh, RT Young Suk Yoo, RNHea Young Yun, RN

Angioplasty Summit 2005 - TCT Asia Pacific42/43_ Venue Lay-Out

- Breakfast Meetings- Lunchtime Activities- Evening Symposium

Pine RoomOak Room

Level 4_ART ROOM

- Breakfast Meetings- Lunchtime Activities- Evening Symposium

Daffodil RoomOrchid Room

Level 3_COSMOS ROOM

Faculty Lounge I - Faculty Lunch Provided

Preview Room (Studio)- Speaker’s Ready Room

Level 2_PRESIDIO ROOM

SHERATON GRANDE WALKERHILL SEOUL HOTEL

Tutorial Auditorium (Mugunghwa Grand Ballroom I, II)- State-of-the-Art Lectures and Live Case Transmissions- Breakfast Meetings- Lunchtime Activities

Mugunghwa Grand Ballroom I- Evening Symposium

Mugunghwa Grand Ballroom II- Evening Symposium

Mugunghwa Grand Ballroom IV- Breakfast Meetings- Lunchtime Activities

Calla Room- Breakfast Meetings- Lunchtime Activities

Translation Receiver Distribution DeskInformation Desk

- Industry Exhibit Hall- Poster Abstract Presentations- Book Sales Booths- Cyber Station- Exhibit Help Desk- Lunch Boxes

Information Desk

Level B1_EXHIBIT HALL(Parking Lot)

Level 1_MUGUNGHWA GRAND BALLROOM

Venue Lay-Out_

W-HOTEL

Faculty Lounge II - Faculty Lunch Provided

Main Arena- Plenary Sessions and Live Case Demonstrations- TCT Asia Pacific Session- EuroPCR Session- Nurse & Technologist Symposium

Free Function- CVRF Asia Booth (Secretariat)- Educational Exhibit Booths (APIA , CCT, TCT, TOPIC) - Bag Distribution Desk- Cyber Station- Translation Receiver Distribution Desk

Information Desk

Level B1_IDA ROOM

Registration BoothsShuttle Limousine : W-Hotel Asan Medical Center

Level B3

Level B2_ VISTA HALL

Exhibit BoothLay-Out 41P

april 26 - 28, 2006 · 2005-04-22 · about cvrf angioplasty summit 2005 - tct asia pacific lay-out...

Documents